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Abstract
ADP-ribosylation is one of many biologically significant protein post-translational
modifications (PTMs) that received considerable research interest in the past decade. The
first part of this work presents the analysis of ADP-ribosylation, with special focus on the
catalytic domain of the enzyme ARTD-10. The application of capillary electrophoresis (CE)
is proposed in this work to separate the in vitro enzymatic mono-ADP-ribosylated ARTD-10
catalytic domain and its unmodified form.
Another important aspect of CE is sample preparation.

The effectiveness and

efficiency for in-vial reaction, in-capillary mixing reaction and on-capillary-tip reaction by
performing methyl esterification on phophopeptides were investigated, in the context of submicroliter sample handling in an attempt to provide insight into the integration of such incapillary derivatization with sample enrichment step in the near future. In this work, a
miniaturized in-capillary methyl esterification method was developed, allowing the efficient
sample handling of sub-µL quantities as a scaled-down sample preparation approach.

Keywords
capillary electrophoresis, proteins, peptides, ADP-ribosylation, ARTD-10, phosphorylation,
mass spectrometry, sample preparation, sub-microliter volume, derivatization, methyl
esterification
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Chapter 1.

Introduction

2

Protein Post-Translational Modifications

1.1

Life is defined by the intricate interplay of a diversity of biomolecules, the
naturally occurring molecules that are found in or more accurately, produced by living
organisms.

Among various types of biomolecules, peptides and proteins play a

profoundly significant role in the regulation of many vital processes and therefore are
considered as the most important biologically active substances. Hence, the study of
proteins and peptides are of great research interest.

1.1.1

General Remarks
The three-dimensional (3D) protein structure is predominantly determined by the

primary sequence (linear alignment of the constituent amino acid residues), which is
dictated by the genetic code, while the real-time dynamics and structural, functional
diversity of proteins are generally modulated by the incorporation of different
modifications.1 As two important building blocks of life, DNA and protein lead pivotal
roles in a diversity of biological processes. During gene expression, the information
(genetic code) stored in DNA is transcribed onto messenger RNA (mRNA), then is
passed onto transfer RNA (tRNA) via translation and used for the biosynthesis of
functional gene products, most commonly proteins. As the central dogma of molecular
biology (Figure 1.1) proposes, the transcription of DNA together with the translation of
RNA contributes to the final synthesis of proteins.
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Figure 1.1 Schematic representation of central dogma of molecular biology.
Post-translational modification (PTM), as the name indicates, is the chemical
alteration to the structure of a protein among the last steps in the protein biosynthesis,
namely translation. To be more specific, PTM denotes changes in the polypeptide chain
resulting from either the addition or removal of distinct chemical moieties to amino acid
residues, proteolytic cleavage, or the introduction of covalent crosslinks between domains
of the protein.2 Typically, protein PTM is catalyzed by an associated class of highly
substrate-specific enzymes. It can also be produced by proteolytic cleavage or by adding
a modifying group to one or more amino acid residues. PTM is ubiquitous in cells since
almost every mature eukaryotic protein becomes covalently modified during its synthesis,
cellular targeting, or regulation.3, 4
As key regulators of a variety of protein activities and functions, PTMs are known
to have an important involvement with mechanisms for controlling intracellular protein
functions, also possibly related to the regulation of enzymatic activity, modulation of
molecular processes, stabilization of protein tertiary/quaternary structures, and/or changes
in the lifetime of the modified protein species.5

PTMs alter intrinsic properties of

proteins such as subcellular localization, turnover, and interactions with other proteins.
Moreover, the implications of various post-translationally modified proteins and their

4

substrates have been discovered in many human diseases and ailments, including cancers,
diabetes and numerous neurological disorders.4
PTMs can be primarily categorized by the types of functional groups attached (or
detached) covalently to the particular amino acid residues, for instance, the addition of
small chemical groups like methyl groups known as methylation and removal of
phosphate groups known as dephosphorylation. There also exist other types of PTMs,
such as ubiquitylation, to covalently couple ubiquitin (a 76-residue protein instead of
chemical groups) to target proteins.6 Many types of known PTMs have been discovered
serendipitously and many more remain yet to be discovered. With the introduction of
different biochemical functional groups to specific amino acid residues of proteins, PTMs
considerably expand nature's repertoire by enhancing the proteome diversity as well as by
broadening the range of protein structures and functions.

1.1.2

Methylation
Protein methylation typically takes place at arginine, lysine, histidine, proline

residues as well as carboxyl groups. The transfer of methyl groups to nitrogen or oxygen
(N- and O-methylation, respectively) to amino acid side chains increases the
hydrophobicity of the protein and can neutralize a negative amino acid charge when
bound to carboxylic acids. Methylation reactions occurring on carboxyl groups can be
reversible and modulate the activity of the target protein, while those on nitrogen atoms
at the N-terminus and on side-chains are usually irreversible. In general, methylation
bears implications in the regulation of many cellular processes including protein stability,
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transcription (gene expression), cellular proliferation, RNA processing and transport,
translation, signal transduction, DNA repair, apoptosis etc.7-9

1.1.3

Phosphorylation
Phosphorylation, essentially at serine (Ser), threonine (Thr), and tyrosine (Tyr)

residues of proteins, is considered to be one of the most important and well-studied
protein PTMs among the more than 200 known examples. In eukaryotic cells, large
proportion of protein phosphorylation takes place on hydroxylated amino acids (Ophosphorylation) with Ser phosphorylation accounting for ~90%, Thr phosphorylation for
~10% and Tyr phosphorylation for only ~0.05% of all phosphorylated amino acids.10
Reversible phosphorylation is an essential regulator of cellular functions with
broad implications in many cellular signaling and regulatory mechanisms. The repertoire
of phosphorylation sites in a proteome (phosphoproteome) is dynamic and complex.
Reversible phosphorylation events are crucially involved in a range of dynamic
biological regulatory mechanisms that trigger essential cellular signaling processes,
through which cells modulate protein activity in response to environmental stimuli.
Therefore, phosphorylation is believed to play a critical role in the regulation of many
important cellular processes such as controlling the cell cycle (cell division, growth,
differentiation, apoptosis and metabolism), protein-protein interactions, and signal
transduction pathways as well.9,

11

It is estimated that in eukaryotic cells of higher

organisms, up to one third of all proteins are phosphorylated at any given time and the
corresponding protein kinases or phosphatases are estimated to constitute between 2–5%
of the human genome codes.12
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1.1.4

Glycosylation
Protein glycosylation is acknowledged as one of the key and most diverse PTMs

in eukaryotic cells, with significant effects on cell recognition, protein folding,
conformation, distribution, stability and activity. Also known for altered glycosylation is
its influence on the immune system and implications in several inflammatory diseases,
cancers, and congenital disorders.13 At least 50% of human proteins are glycosylated and
in some estimation the ratio is up to 70%.14 In contrast to the non-enzymatic process
glycation, glycosylation involves the enzymatic addition and removal of carbohydrate
residues on proteins. Two major groups of glycosylation can be defined based on the
addition of carbohydrates in the form of aspargine-linked (N-linked) or serine/threoninelinked (O-linked) oligosaccharides.

The pronounced heterogeneity of glycosylation

manifests itself in the diverse selection of glycan structures attached to protein substrates,
ranging from simple monosaccharide modifications to highly complex branched
polysaccharides.
The physicochemical properties of a recombinant protein can be largely altered
with the addition of glycans to the polypeptide backbone, including its folding, selfassociation, protection from proteolytic degradation, resistance to thermal denaturation,
solubility and protein sorting within the cell.

It can also alter essential biological

functions, such as the immunogenicity, signal transduction pathways, specific activity
and ligand-receptor interactions of the protein.9 For example, glycosylation results in a
variety of structural and functional roles in membrane and secreted proteins.

7

1.1.5

ADP-ribosylation
The discovery of poly-ADP-ribosylation, initially as an unconventional protein

PTM, can be traced back to almost 50 years ago, when Chambon and his coworkers first
described the homopolymer of ADP-ribose (ADPr) units, i.e. poly-ADP-ribose (PAR),
derived from nicotinamide adenine dinucleotide (NAD+) hydrolysis with the
simultaneous release of nicotinamide.15 Ever since its discovery, tremendous efforts have
been made to develop a comprehensive understanding of ADP-ribosylation. In the late
1980s researchers reported the isolation of poly(ADP-ribose) polymerase (PARP;
subdivided as PARP-1 afterwards), the enzyme dedicated to this PTM activity, ensuing
the next period of intensive biochemical and structural characterization work.16
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Figure 1.2 Schematic diagram of mono-ADP-ribosylation and poly-ADP-ribosylation:
the enzyme-catalyzed, reversible PTM of acceptor protein by a single ADPr group for
mono-ADP-ribosylation and by PAR polymers for poly-ADP-ribosylation.
As is shown in Figure 1.2, a typical process of poly-ADP-ribosylation, the
formation of branched or unbranched chains of PAR units onto protein side chains, can
be subdivided into three parts: the initiation, the elongation and the branching reaction.
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The initiation is characterized by the attachment of a single ADPr moiety from NAD+ to
the γ-carboxy group of glutamic acid residues or less likely aspartic acid residues, which
is also referred to as mono-ADP-ribosylation. This gives rise to the formation of a labile
ester bond that is unstable in dilute alkali and neutral hydroxylamine. The elongation
step involves the transfer of further PAR moieties to an already attached ADPr unit
through glycosidic linkages, while the branching reaction usually occurs in an irregular
manner.17 Poly-ADP-ribosylation is a dynamic process, with the half-life of the PAR
polymer being shorter than 1 min in vivo.18 The breakdown of PAR is mediated by polyADP-ribose glycohydrolase (PARG), the only known enzyme that hydrolyses the
glycosidic bond between ADPr units, and thereby liberates free ADPr.19
In general, the enzymes responsible for mono-ADP-ribosylation are either
bacterial pathogenic toxins or endogenous cellular ADP-ribosyl-transferases (ARTs).
The latter include members of three different families of proteins: the well characterized
arginine-specific ecto-enzymes ARTCs (clostridial-toxin-like ARTs), two sirtuins and,
more recently, novel members of the ARTD (diphtheria-toxin-like ART) family that have
been suggested to act as cellular mono-ADP-ribosyl-transferases (mARTs).20
ARTs/PARPs use NAD+ as a substrate to add PAR to other proteins or themselves via
auto-modification.
ADPr can be hazardous to the cell since it can modify histidine, lysine and
cysteine residues of proteins by non-enzymatic glycation and leads to inhibition of ATPactivated K+ channels. Moreover, the net effect of the covalent attachment of negatively
charged long-chain PAR is thought to be drastically altering the properties as well as
activities of the protein acceptors through both steric and charge effects, ultimately

10

modulating protein-protein interactions, enzymatic activities or subcellular localization.21,
22

As a result, ADP-ribosylation changes the activities and properties of the target

proteins typically by interfering with the binding to other macromolecules. It can also
possibly create new sites of interactions with different protein modules.23

Overall

speaking, the reversible ADP-ribosylation reaction bears significant implications with
many physiological processes through regulation of multiple cellular processes covering
maintenance of genomic stability (through regulation of DNA repair), inter- and intracellular signaling, transcription, gene expression, membrane transport regulation (protein
localization), necrosis, and programmed cell death (apoptosis), DNA repair pathways,
apoptosis and cell cycle control.22, 24, 25 It occurs in almost all nuleated cells of mammals,
plants and lower eukaryotes, but is absent in yeast.15 Typically, PARP enzymes have
well-established roles as potent bacterial toxins and metabolic regulators, carrying
relevancy to many diseases including inflammatory diseases, diabetes and cancers.26

1.2

Mass Spectrometry in the Analysis of PTMs

1.2.1

General Remarks
The concept of “proteome” (the PROTEin complement of a genOME) was first

proposed in 1996 by Andrej Shevchenko et al.27 In the post-genomic era, proteomics, the
analysis of a proteome i.e. the large-scale study of proteins particularly their structures
and functions is gaining importance, as the PTM properties of proteins cannot be
determined from the DNA sequence alone using the mature polymerase chain reaction
(PCR) techniques. Numerous routine or specialized approaches have been developed to
analyze protein PTMs qualitatively or quantitatively.

The core principles of many
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detection methods are elegantly simple: to discriminate the difference of an experimental
variant corresponding to the introduction of a specific PTM on the target protein/peptide.
By detecting the characteristic mass change (increment or deficit) as a result of the
modification, mass spectrometry (MS) offers an attractively straightforward way of the
identification and characterization for a multiple of protein PTMs. The increasingly
widespread use of MS in the analysis of PTM is due in large part to its ability to solve
structural problems not easily handled by conventional methods.
MS techniques, especially electrospray ionization mass spectrometry (ESI-MS)
and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), are to
date the most powerful and indispensable tool to achieve global proteomic profiling. In a
narrower sense, MS-based proteomics encompasses techniques for protein quantification
and determination of protein primary structure, including PTMs as well as protein-protein
interactions. The elucidation of protein PTMs remains an important branch of MS
applications, including the identification of post-translationally modified proteins, the
determination of PTM sites on proteins/peptides and site-specific quantitation of protein
PTMs as well.

12

1.2.2

Instrumentation of Mass Spectrometers

Figure 1.3 Simplified schematic for the typical composition of a mass spectrometer.
Simplistically, a mass spectrometer is composed of three major parts: an ion
source, a mass analyzer that separates analyte ions by mass-to-charge ratio (m/z), and a
detector that registers the number of ions at each m/z value. Details of the ion source and
mass analyzer tend to define the type of instrument and the functionalities of MS systems.

1.2.3

Soft Ionization Techniques for Protein and Peptide Analysis

1.2.3.1

Electrospray Ionization

As one of the two “soft” ionization techniques enabling minimal fragmentation
during the ionization process, electrospray ionization (ESI) was initially reported in 1989,
allowing for sensitive detection of large, non-volatile and thermally labile molecules by
MS.28,

29

ESI generates a continuous supply of ions from the liquid phase, where a

charged analyte solution is emitted from a nozzle, needle, or capillary in the presence of a
strong electric field. One feature of ESI is that the acidic conditions used to generate
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positively charged droplets tend to protonate all available basic sites in the analytes,
leading to the generation of multiply protonated species.

1.2.3.2

Matrix-assisted Laser Desorption/Ionization

Matrix-assisted laser desorption/ionization (MALDI) is another soft ionization
technique that provides sensitive analysis for a great diversity of analytes, in particular
biopolymers such as proteins and peptides. Ever since its first inception in the late 1980s
by Karas et al. and Tanaka et al. as a method of forming intact gas-phase ions from large
and labile molecules, MALDI-MS has developed into one of the most essential analytical
techniques in life science with widespread applications in the characterization of peptides,
proteins, as well as organic polymers.30 The substantial contribution by ESI and MALDI
to the analysis of biological macromolecules was acknowledged as a shared Nobel Prize
in Chemistry in 2002.
By definition, the term “matrix” refers to small, laser absorbing organic molecules
that are used in high molar excess over the analyte molecules and co-crystallize with
them on the MALDI target plate to form a homogeneous layer of small crystals. This cocrystallization leads to the co-desorption (evaporation into the gas phase upon irradiation
with a pulsed laser) of intact non-volatile, labile molecules with the matrix and
concurrently, the ionization of sample molecules. The function of the matrix is to absorb
and accumulate the energy of the laser irradiation and, thus, minimize possible sample
damage and fragmentation. The entire desorption/ionization process represents the core
of the MALDI principle.
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1.2.3.3

Comparison between MALDI and ESI

Both ESI and MALDI have their advantages and disadvantages and the choice of
instrument depends on the sample and level of accuracy and information that is required.
ESI is often linked to HPLC instrumentation, while MALDI-TOF is more adapted to
high-throughput approaches and therefore more suitable to large-scale proteomics.31
Since the advent of MS-oriented proteomic studies, ESI has often been employed in
peptide sequencing after HPLC separation, while MALDI has been used to mass
fingerprint mixtures of peptides. This division of effort is derived from the fact that ESI
can be easily coupled on-line to front-end fractionation such as HPLC since both
techniques are liquid-based, and MALDI can readily be implemented for the analysis of
peptide mixtures without resorting to separation. As a result of the vacuum conditions
required for MALDI ionization process to take place, its online coupling with liquidphase separation techniques remains less straightforward.32-34 Separation of analytes
prior to MALDI, however, reduces ion suppression and leads to higher signal-to-noise
ratios (S/N) and greater sensitivity. With respect to robustness, higher tolerance of
contaminations such as salt additives, faster speed, higher accessible m/z range and
simple interpretation of the acquired spectra due to the exclusive production of
predominantly singly-charged ions, MALDI is favored over ESI.

1.2.3.4

MALDI-TOF

A time-of-flight (TOF) mass analyzer separates accelerated ions based on the
differences between their velocities.

Recent years has witnessed the tremendous

commercial renaissance of the TOF mass analyzers, to which MALDI sources are
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generally interfaced due to the fact that both techniques are pulse-based. Amenable to
the analysis of high m/z ranges, MALDI-TOF MS is a powerful tool for analyzing
peptides and proteins by linear or reflectron mode (further reading available in Appendix
A).

It has successfully been implemented in the accurate determination of

proteins/peptide masses with high sensitivity (low fmol range) and good mass accuracy
(low ppm range), providing attractive analytical features for the unbiased analysis of
protein PTMs.35

1.2.4

Tandem Mass Spectrometry
Currently more than 300 different types of known and new PTMs are regularly

discovered. Most PTMs can be detected by monitoring the corresponding mass shifts,
attributed to the unambiguous information provided by either MALDI-MS or ESI-MS
concerning a mass increment or a mass deficit compared to the original unmodified
protein (Figure 1.4). Nevertheless, another critical issue and also major challenge for
PTM analysis remains to be the localization of PTM sites. To date, the most frequently
used method for the full identification and in-depth characterization of protein PTM
patterns is tandem mass spectrometry (MS/MS) combined with protein sequence database
like Mascot.36-38 Large-scale, quantitative analysis of proteins by MS/MS has been
proved to reveal novel patterns and functions of PTMs in cellular signaling networks and
biomolecular structures.
MS-based protein analysis can be performed using sequence-specific peptide
fragmentation or peptide mass fingerprinting (PMF), also known as peptide mass
mapping. The characterization of unknown proteins and the determination of PTM
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locations by MS/MS are generally involved with a two-step process of sequencing
peptides obtained from PMF and database search. As is illustrated by Figure 1.4, after
the molecular mass determination of the peptide through MS analysis, the peptide peak of
interest is isolated and subject to further fragmentation by collision induced dissociation
(CID).37 The resulting peptide fragments are subsequently directed to a second mass
analyzer. Fragmentation of the peptide amide bond produces a set of fragment ions that
generate a ladder-like readout of the sequence in the MS/MS profile. The presence of a
PTM alters the mass of the modified amino acid residue together with the peptide, and
the information concerning the mass and identity of the PTM as well as the position of
the modified amino acid residue can in turn be revealed by MS/MS.

Figure 1.4 Schematic representation of peptide analysis by MS for detecting PTMs and
peptide sequencing by MS/MS for mapping PTMs.
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1.3

Separation Techniques for PTM Analysis and Protein
Sample Preparation
The fact that proteins carry many modifications increases the molecular

heterogeneity and diversity of gene products. Although MS-based proteomics research
has enjoyed tremendous success, it is still confronted with significant challenges for such
a complicated large-scale proteome research. Firstly, it is conceivable that for complex
biological samples, particularly for protein mixtures that contain thousands of different
protein species with several orders of magnitude variation in abundance, the extent of
pre-fractionation correlates with the number of detectable proteins and their PTMs.
Secondly, it is also well known that proteins are dynamic with a large range of expression
levels (protein concentrations), which means a large proportion of proteins exist in
extremely low abundance and therefore are likely to suffer from MS signal suppression
by the more abundant ones, such as the biologically significant phosphoproteins with low
stoichiometry.39 The successful detection and characterization of these low-abundance
species, as a consequence, rely greatly on sample pretreatment such as fractionation,
enrichment and derivatization. Last but not least, purification steps prior to MS analysis
contribute to the removal of contaminants that would interfere with MS detection. In the
domain of proteomics, purification or pre-fractionation techniques encompass majorly
chromatographic and electrophoretic methods, as well as affinity capture/enrichment and
immuno-precipitation (IP), all of which can be readily interfaced to MS in an online or
offline fashion to fulfill the task of global PTM profiling.40, 41
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1.3.1

Gel Electrophoresis

1.3.1.1

One-Dimensional Electrophoresis

In one-dimensional gel electrophoresis (1D-GE), the separation of the analytes in
a single dimension is achieved by on-gel electrophoretic migration induced by a high
potential difference, based on their diversified molecular weight (MW). Sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is highly applicable to the
separation of multifarious components in a protein mixture, and is often the final stage of
purification of individual proteins. The main advantages of SDS-PAGE are simplicity,
good reproducibility, and wide mass range. However, it is typically not suitable for the
differentiation between highly related protein species.

Only PTM that generates a

considerable MW difference can be detected on a 1-D gel as an observable band shift.

1.3.1.2

Two-Dimensional Electrophoresis

Separations in single dimension are inadequate to effectively resolve complex
protein mixtures. With the advent of two-dimensional electrophoresis (2-DE) technique,
considerably complex protein mixtures are able to be separated, resulting in enormous
improvements on the identification and characterization of different protein species and
isoforms. The 2-DE separation is based on two orthogonal characters, isoelectric point
(pI; the pH at which an analyte display a net neutral charge) and MW, and provides
exceptionally high resolution is the combination of isoelectric focusing (IEF; first
dimension) and SDS-PAGE (second dimension). The separated proteins form spots on
the plate, which may be cut out for further analysis. Despite its labor-intensive and time-
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consuming operation, 2-DE are very powerful and are capable of resolving complicated
protein mixtures, regarded as one of the most important and broadly applied techniques in
the field of proteomics.
Noteworthy, 2-DE separation of proteins also allows monitoring and investigation
of post-translationally modified species due to corresponding shifts in pI values and/or
MW upon covalent modifications of proteins.

It often has sufficient resolution to

separate the modification states of a protein directly.42 For instance, by introducing a
negatively charged phosphate, phosphorylation changes the overall protein charge and is
often indicated by a horizontal trail of protein spots on the 2-D gel.2
However, as a gel-based method, 2-DE suffers from a series of limitations,
including limited sample capacity, low detection sensitivity, difficulty to separate
transmembrane proteins and limited throughput.

In addition, the detection of low-

abundance proteins can be hampered by proteins with similar sizes and charges or by
expression levels below the current detection limits of the analytical techniques used.
Other drawbacks with regard to gel-to-gel reproducibility have also to be addressed.

1.3.2

Chromatography
As an alternative to gel-based methods, chromatographic techniques provide both

analytical and preparative applications in the field of proteomics. In many cases, proteins
are usually converted into peptides by treatment with sequence-specific proteases or by
chemical cleavage prior to chromatographic separations, since peptides are more
amenable to MS and MS/MS analysis than intact proteins.

Conventional liquid

chromatographic (LC) methods have been established for the separation of proteins and
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peptides based on their molecular mass, charge (e.g. strong cation exchange [SCE]
chromatography) or hydrophobicity (e.g. reversed-phase chromatography [RPC]).43
Reversed-phase high performance liquid chromatography (RP-HPLC) has been
extensively used for sample preparation and fractionation of proteins and peptides with
excellent recovery and good resolution. However, it faces problems with the analysis of
very hydrophobic proteins and hydrophilic peptides, and it may not be easy to achieve
high-resolution LC separations of highly similar protein species, and hence this
technology is classically coupled with MS for the identification and characterization of
PTMs.44 One specific analytical approach termed “MudPIT” (multidimensional peptide
identification technology), is typically involved with the combination of two stages of
chromatographic separation (SCE and RPC) followed by MS analysis.45 Due to higher
resolving power, MudPIT may show greater potential in PTM studies.
Affinity protein enrichment, as a unique branch of chromatography, also receives
wide-range applications in the study of PTMs, and is well adapted to MS analysis for
purification instead of pre-fractionation purpose.

A good exemplification is

phosphopeptide enrichment, which is prevalently achieved by metal oxide affinity
chromatography (MOAC) or immobilized metal ion affinity chromatography (IMAC)
with strong binding affinity for phosphorylated amino acid residues.

Notably, the

phosphoproteome sequence coverage can be enhanced by the combination of the methods,
which is referred to an approach named SIMAC (Sequential elution from IMAC).46
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1.3.3

MS-Based Proteomics Workflow
The most widely accepted approach in proteomics based on MS characterization

is usually referred to as “bottom up” strategy. Typically, Figure 1.5 shows a general
workflow of MS-based bottom-up proteomics, incorporating protein fractionation by gelbased methods (1-GE, 2-DE), LC-based methods (RPLC, SEC, IEC or MudPIT) or
protein affinity enrichment for any particular analyte of interest, followed by proteolytic
digestion, analysis of the resulting peptide mixture (after peptide separation or sample
clean-up if necessary) using various MS approaches and finally, database search.47, 48
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Figure 1.5 Flowchart depicting the generic bottom-up proteomics workflow. Gel-based,
LC-based or affinity-based separation of protein mixtures is utilized in combination with
MS or MS/MS analysis.
Nonetheless, the low protein sequence coverage often obtained using the bottomup approach hinders the comprehensive characterization of protein PTMs.48
Alternatively, “top down” approaches have been described.

Top-down proteomic

analysis is avoids any enzymatic digestion, instead intact proteins are subject to prefractionation and MS fragmentation. This is especially effective in unraveling complex
PTM patterns.49,

50

Effective top-down analysis, however, is still confined to

requirements for extremely high mass resolution, mass accuracy and the ability of
efficiently fragmenting large ions.
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1.4

Capillary Electrophoresis in PTM Analysis and
Protein Sample Preparation

1.4.1

General Remarks
Nowadays, as a separation tool that combines several features of column

chromatography and electrophoresis, and one of the most important analytical techniques
comparable to 2-DE and HPLC, capillary electrophoresis (CE) has become a robust and
versatile analytical implement for a wide variety of analytes with broad ranges of
applications.

Advantages of CE methods over traditional chromatographic methods

include its resolving power, low sample quantity and minimal chemical consumption as
well, while the major limitation is its low sensitivity. Easy automation of the analytical
procedures as well as simplicity of the instrumentation also gains vast popularity for CE
in regular analytical applications, which are advantageous over the tedious 1-GE or 2-DE
procedures. Furthermore, CE exhibits outstanding analytical performance particularly for
proteins and peptides by providing good resolution, high efficiency, minute sample
consumption and often complementary selectivity to conventional chromatographic
separations.51 Although the incorporation of CE separation into the proteomics workflow
is less reported, its importance in bioanalysis increases with the growing effort to
understand the composition and function of proteins in living bodies including the
significant PTM properties of proteins.52, 53
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1.4.2

Instrumentation and Principles of Capillary Zone
Electrophoresis
Capillary zone electrophoresis (CZE) is the main CE separation mode utilized for

the analysis of biomolecules and has been widely applied in peptide mapping and for the
evaluation of the charge heterogeneity of proteins.54 In CZE it is desirable to be able to
tune the composition of the background electrolyte (BGE) so that separations can be
optimized. Moreover, the possibility of using volatile BGE provides a high compatibility
of CZE with MS. Proteins and most peptides are ionogenic substances which also bear
other functionalities such as hydrogen-bonding regions, hydrophobic patches and
biospecific interaction sites that may interact to different extents with the components of
the BGE. Depending on the chemical nature of the proteins/peptides and the ionic
species in solution, such interactions can lead to significant variations in the
electrophoretic mobility of these analytes that can greatly affect their selective separation
by CZE.55
One key feature of CE is the simplicity of the instrumentation as is depicted in
Figure 1.6. A typical CE set-up consists of a capillary, two buffer reservoirs, a sample
reservoir, a high voltage supply, pressure system for the rinsing of the capillary and a UV
detector. An electrical field of up to 30 kV may be applied through electrodes immersed
in the electrolyte solution in the two buffer reservoirs. The capillary is filled with buffer
and an injection is carried out by moving the capillary from the buffer reservoir of the
inlet side to the sample reservoir. Frequently-used modes of CE sample injection include
hydrodynamic injection which is driven by pressure, and electrokinetic injection which is
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driven by voltage. After injection, the capillary is positioned back to the buffer reservoir
followed by voltage application, and the separation takes place. The CE separation of
charged compounds is dependent on the differential migration of analytes in an applied
electric field.

Figure 1.6 Schematic of typical CE instrumentation. The enlarged section shows the
directions of the electrophoretic mobility and electroosmotic flow.
Electroosmotic flow (EOF), defined as a bulk flow of buffer through the CE
system in the presence of an electric field, is a critical factor in many CE studies. The
generation of EOF pheonomenon is unique for CE systems, and is a direct result of the
surface charges on the interior capillary wall. That is, the ionization of the surface silanol
groups (-SiOH) in a fused silica capillary occurs under aqueous conditions above pH 4,
resulting in net negative charges (-SiO-). As a consequence, the electric double-layer
forms at the silica-buffer interface in order to maintain electroneutrality, i.e. the buffer
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cations adsorb onto the anionic wall via electrostatic interactions and form a rigid or
immobile Stern layer, while the remaining buffer cations form a loose diffuse-layer
(Figure 1.7).

When an electric filed is applied through the capillary filled with

electrolytes, the cations in the diffuse layer will start to migrate towards the cathodic end
of the capillary. Since they are solvated in the buffer, their moment drags the bulk
solution with it. The characteristic of the EOF is the flat flow profile, in contrast to the
pressure driven parabolic (laminar) flow usually obtained in chromatographic analysis
(Figure 1.8). This is because its driving force is evenly distributed along the capillary,
which means that no pressure drops are encountered and the flow velocity is uniform
across the capillary.

Zone broadening can be minimized with such a flat profile,

contributing to high separation efficiencies.

Figure 1.7 Schematic representation of the generation of EOF. Ψx is the potential at the
distance x from the surface, Ψ0 is the surface potential, Ψδ is the stern layer potential and
ζ is the zeta potential.
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Figure 1.8 Schematics showing the (A) EOF flat flow profile and (B) laminar flow
profile.
Apparent mobility (µa), the mobility of an analyte in the presence of EOF, is
expressed as the vectorial combination of electrophoretic mobility (µe) and
electroosmotic mobility (µeof).
Equation 1.1
where µa and µeof can be directly calculated from the migration time of the
analytes and the neutral EOF marker, respectively. A negative value of µeof is indicative
of the anodic direction of the EOF, whereas a positive value of µeof indicates that EOF is
directed towards the cathode. Notable is that µeof is independent of the electric field.
Given a buffer of specific pH, the electrophoretic mobility of a charged species toward
the electrode of opposite charge can be approximated from the Debye–Hückel–Henry
theory,

Equation 1.2
where q is the net charge of the ion, η is the buffer viscosity, and r is the ionic
radius of the analyte. The charge q can be determined by the buffer pH, whereas the
radius r is affected by many factors including counter-ion effects, non-spherical shape or
other non-ideal behaviors of molecules. The size of an analyte is often approximated as
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the mass of the molecule, and thus the analytes are separated based on their “charge-tosize ratio”, or in some circumstances “charge-to-mass ratio”. Naturally, an ion with
higher charge and smaller size will have greater mobility, whereas lower charge and
larger size means lower mobility. Deduced from this equation, µe is also proportional to
the charge-to-mass ratio of the analyte:

Equation 1.3
Since different ions have different charge-to-size ratios, separation can take place
due to differentiated electrophoretic mobility. Generally speaking, at a given EOF,
analytes with smaller sizes and higher net charges tend to migrate faster toward the
electrode of opposite charge in a CE run, as is illustrated in Figure 1.9.

+

Forward EOF
-+
--+ Cationic species
- Anionic species
Neutral species

Detector
++

-

Buffer zone
Sample zone
Electroosmotic mobility
Electrophoretic mobility

Figure 1.9 Schematic representation of in-capillary ion migration behavior in an
uncoated capillary.

1.4.3

PTM Analysis by CE Separation
To be specific, many protein PTMs result in a change of net charge of the

modified protein and thus also of its electrophoretic mobility.

With outstanding

separation efficiencies, CE is envisioned to have great potential for the separation of a
variety of protein PTMs in a single run. An important feature of CE separation of
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peptides is that their electrophoretic migration properties as a function of pH can be
predicted from theoretical models, because of the amino acid residues with variant
ionizable side chains that alter the charge distribution upon environmental pH change.42
The nature of most conventional PTMs remains the attachment or detachment of certain
chemical/biological groups, which bring about both mass change and charge variation.
Going back to Equation 1.3, which states the effect of both charge and MW on the CE
electromigration of analytes, it is reasonable to come up with the idea of separation-based
identification of PTMs by modeling the electrophoretic mobility difference between the
modified form and the unmodified counterpart. It has been reported that a number of
peptides contain PTMs which can be readily detected based upon their relative
electrophoretic mobility in CE.56 Furthermore, correctly accounting for the total charge
in the post-translationally modified analytes allows for the correlation of the expected
mobility with the measured mobility.
A critical limitation and also challenging task of CE in the analysis of
biomolecules that has to be addressed, however, is the protein adsorption issue.
Specifically, positively charged domains of the analyzed proteins preferentially adsorb to
negatively charged capillary interior surface and vice versa.

Such protein-wall

interactions can result in peak tailing, band broadening, poor separation efficiencies, low
sample recoveries, as well as non-reproducible migration time. To inhibit or circumvent
these effects, several attempts have been made including high pH, high ionic strength and
the incorporation of zwitterionic additives in the BGE. The most popular approach to
minimize sample-wall interactions remains the manipulation of surface charge of the
capillary wall, simply achieved by different kinds of capillary coating techniques, either
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dynamic or static.57

Even though dynamic coatings are easy to apply and can be

produced simply by flushing the capillary with solutions of the adsorptive coating agents,
they do not eliminate EOF and sample adsorptions completely. On the other hand, static
coatings, the permanent and covalent attachment of the coating materials to the capillary
inner surface, are generally more difficult to produce and regenerate but more effective at
eliminating protein adsorption, and more stable compared to dynamic coatings.58

1.4.4

CE Sample Preparation Coupling to MALDI-MS
Owing to rapid analysis, high resolving power and low sample consumption, CE

is gaining growing interest in the field of proteomics. Nevertheless, to ensure unbiased
characterization, CE-MS coupling is indispensable as unambiguous mass information can
be obtained via high-resolution MS techniques, which is essentially crucial to the
confident determination of PTMs in particular. As the sample capacity and concentration
sensitivity in CE is low, the high sensitivity of MS makes it possible to detect low
abundant species. Furthermore, the capability of small-volume sample handling by CE is
favorable to the downsized analysis. Besides, despite the exceptional analyzing power
and good capacity for sample complexity of MS, to gain the best sensitivity and
selectivity by reducing the risk of ion suppression, a separation stage prior to the MS
analysis is usually fundamental. The coupling of a rapid and efficient CE separation
technique with highly sensitive MS detection can therefore offer powerful analytical
performance and further extend the utility of both techniques. Nowadays, CE-MS has
received wide-range applications for many analytical purposes and is in particular
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suitable the analysis of highly polar ionogenic and charged substances which could be
difficult to handle using LC-MS methodology.
Another exciting aspect of CE sample preparation in addition to separation prior
to MS remains the development of in-capillary sample pretreatment procedures.
Miniaturization is a common trend in contemporary analytical developments, because of
the need to perform large numbers of analyses on biological materials of interest. This
can be fulfilled by CE due to its ability of small-sample-volume handling. The small
dimension of the capillary as well as the ability of small-volume sample handling (at subµL level) makes it an attractive technique to develop CE-based miniaturized platform for
downsizing purpose.
Among a diversity of MS techniques, ESI-MS can be most conveniently
interfaced to CE since both techniques are flow-based. However, compared to ESI,
MALDI exhibits higher tolerance against contaminants, CE buffer salts and
additives/coatings used for prevention of sample adsorption onto the capillary wall. To
combine CE with MALDI-MS offers an opportunity to separate and identify analytes
with potential for automation and high throughput.

CE provides low sample

consumption, high separation efficiency and strong resolving power while the soft
ionization with MALDI can manage large peptides/proteins with desirable mass accuracy,
resolution, sensitivity together with high throughput capability for large-scale analysis.
However, since the MALDI ionization process is typically undertaken in a vacuum inside
the mass spectrometer, and the electrophoretic separation is hard to maintain during the
fractionation, the practical online interfacing of MALDI-MS with CE is considerably
hampered. Additionally, the offline CE-MALDI-MS coupling is not straightforward due
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to the minute sample volume in CE as low as a few nanoliters.34 In spite of these
technical impediments, either offline or online mode of CE-MALDI-MS hyphenation has
been achieved via different experimental designs.

1.5

Thesis Overview
The overall aim of this thesis was to study protein PTMs especially ADP-

ribosylation, and miniaturized peptide derivatization especially methyl esterification by
taking advantage of CE separation efficiency, small-volume sample handling and
instrumentation, which reflects two major applications of CE, i.e. separation and sample
pretreatment. In combination with CE, MALDI-MS also provides outstanding analytical
performance with regards to biomolecules such as peptides and proteins, and was used in
both experimental approaches with the purpose of identifying specific modifications on
proteins or peptides.

In short, this work can be divided into two body chapters:

separation-based analysis of protein ADP-ribosylation, and in-capillary derivatization for
miniaturized methyl esterification of phosphopeptides.
As an excellent complement to traditional bioanalytical techniques such as HPLC,
1-GE and 2-DE, CE is an extremely powerful separation tool with exceptional separation
efficiency and short analysis time. Therefore, it was considered a promising alternative
to the traditional analytical methodologies for ADP-ribosylation. In chapter 2, qualitative
CE analysis of ADP-ribosylation was performed, with special focus on the catalytic
domain of ARTD-10, an enzyme responsible for plausible mono-ADP-ribosylation. The
purpose of this work was to develop an optimized CE separation mode for ARTD-10 and
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its potential mono-ADP-ribosylated counterpart, in an attempt to elucidate the
biochemical activity of ARTD-10.
One growing area of interest in CE is the development of strategies for integrating
multiple sample pretreatment procedures such as desalting, preconcentration,
derivatization and extraction, which are often time-consuming and labor-intensive in the
conventional approach.59, 60 As a consequence, it is also of interest to take advantage of
the utility of CE’s small-volume sample handling (at sub-µL level) to fulfill miniaturized
sample preparation, such as in-capillary derivatization, in conjugation with specific
sample pretreatment if applicable. In chapter 3, preliminary efforts towards in-capillary
methyl esterification of phosphorylated peptides for MALDI-MS analysis along with oncapillary-tip sample recovery after removal of unfavorable organic solvents were
presented, in an attempt to develop subsequent in-capillary recapture and enrichment of
target molecules by means of either dynamic pH junction or solid phase extraction using
immobilized magnetic beads.
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Chapter 2.

Analysis of ADP-Ribosylation by Capillary
Electrophoresis
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2.1

Introduction
Compared to protein poly-ADP-ribosylation, mono-ADP-ribosylation remains

little explored and recent studies indicate that they have potentially very important roles
to play in a number of complex biological processes like metabolism, cellular signaling,
membrane trafficking, gene regulation, cell proliferation and immunity.1-3

As the

enzymes responsible for mono-ADP-ribosylation reactions, mARTs have gained great
research interest recently. In the past decade, genomic techniques led to the identification
of 18 recognized PARP/ARTD sequences in the human genome, all of which contain a
conserved catalytic domain and additional specificity domains.4 A recent structure-based
classification of PARP family members divide them into three groups based on the
differentiation of their catalytic domains: (1) ARTDs 1–5, which are bona fide
polymerases containing a conserved glutamate (Glu 988 in PARP-1) that defines the
PARP catalytic activity; (2) ARTDs 6–8, 10–12, and 14–16, which are confirmed or
putative mARTs; and (3) ARTDs 9 and 13, which lack key NAD+-binding residues and
the conserved catalytic glutamate residue, are thought to be inactive.5, 6
Despite the general acceptance of such activity-based categorization, the
clarification of the functional aspects of ARTD-10, a nuclear and cytosolic protein with
1025 residues and a C-terminal consensus PARP domain (Figure 2.1), is not that
straightforward.

ARTD-10 (PARP-10) was first reported by Yu et al. to present

polymerase activity as a new member of the PARP family in 2005, in consideration of its
structural homology to RNA recognition motifs and to most of PARP enzymes.1 In their
findings, ARTD-10 was able to poly(ADP-ribosyl)ate itself and core histones.7
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Nevertheless, the presence of a conserved glutamate residue in the active center was still
disputable at that time.

In the meantime, another line of researchers also further

confirmed that the catalytic domain of ARTD-10 possesses active polymerase activity.
Firstly, it was revealed by sequence comparison that a PARP catalytic domain located in
the C-terminal portion of ARTD-10 conserved the most important secondary structures as
well as some of the critical residues for NAD+-binding. Secondly, the ADP-ribosylation
reaction was blocked with the inclusion of a PARP-specific inhibitor 3-aminobenzamide
(3-AB), an indication that the activity of ARTD-10 is analogous to PARP1-catalyzed
poly-ADP-ribosylation.8 In 2008, based on the detailed evaluation of the enzymatic
properties of ARTD-10, Luscher and coworkers demonstrated that ARTD-10 actually
exhibit transferase activity rather than polymerase activity due to the absence of an
otherwise conserved catalytic glutamate in the active site.6 In this work, the authors
suggested that ARTD-10 catalyzes ADP-ribosylation onto glutamic acid or aspartic acid
residues of target proteins, involving a mechanism called substrate-assisted catalysis.
The molecular basis for such substrate-assisted catalysis, which limits the activity of
ARTD-10 to mono-ADP-ribosylation, was proposed on the basis of sequence alignments,
biochemical characterization and molecular modeling.

Intriguingly, PARP-10 is

currently accepted as mART to catalyze mono- instead of poly-ADP-ribosylation
reactions. ARTD-10 does not seem to be capable of modifying cysteine or arginine
residues but rather is suggested to mono-ADP-ribosylate glutamates.2
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Figure 2.1 Protein sequence of full length ARTD-10 (PARP-10). RNA recognition motif
(RRM) (in red), a Gly-rich region (in green), a Glu-rich region (in bluegreen), nuclear
export sequences (NES) (in yellow), and ubiquitin-interaction motifs (UIM) (in bluegreen)
are shown. The PARP domain is shaded in gray.
Recent years have witnessed a tremendous influx of novel techniques that led to a
breathtaking expansion of the ADP-ribosylation research scope. Traditional analytical
approaches in separation, identification and characterization for ADP-ribosylated species
include RP-HPLC coupled with MALDI-MS and ESI-MS, SDS-PAGE, radiolabeling
NAD+.9-11 For SDS-PAGE, only PAR could generate detectable band shift. In previous
studies on ARTD-10 purified from mammalian cells, its transferase instead of
polymerase activity was verified due to the absence of size shift in PAGE gels that
derives from the addition of PAR polymers in contrast to PARP-1.2 However, this poses
a potential drawback for the GE analysis of mono-ADP-ribosylation due to the fact that
the addition of a single ADPr group onto a large protein substrate does not give rise to
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observable band shift on the gel. Nonetheless, it has been reported that radiolabeled
target proteins can be detected by SDS-PAGE autoradiography using radioactively
labeled [32P]-NAD+ as a substrate.12

Radiolabeling technique receives tremendous

success in the detection of ADPr moiety and has been using extensively in all kinds of
relevant studies.13 However, a major issue exists for the potential hazard of radiolabeling,
which is undesirable for routine analysis. Last but not least, the idea of generating
antibodies that recognize mono-ADP-ribosylated targets might sound straightforward, but
the development of this approach is still in its infancy and suffers from low specificity,
namely the trend of showing cross reactivity with other poly-ADP-ribosylated species.12
MS/MS (or MS sequencing) is also a well-established method for the analysis of
ADP-ribosylation particularly the identification of modification sites.14 Specific ADPribosylated amino acid residues can be identified given that the purified ADP-ribosylated
protein is subject to protease digestion. The resulting peptides are fractionated by HPLC
and subsequently identified by MS sequencing. The use of LC coupled to MS/MS to
identify and characterize sites of ADP-ribosylation has also been reported.15 However,
due to the complexity of the modification and the fragmentation pattern in MS/MS CID
experiments, the identification of ADP-ribosylation sites in complex mixtures is difficult.
That is, the (ester) linkage between the ADPr and the acceptor residue is labile under MS
condition, and ADPr itself is prone to fragmentation due to the labile pyrophosphate and
adenine moieties, and the presence of a PTM on a peptide can redirect fragmentation
patterns to make the sequence assignment difficult.15, 16 To facilitate the MS analysis and
detection of ADP-ribosylation, two new techniques have been developed recently. In one
approach, the fragmentation of ADPr-containing tryptic peptides generates characteristic

44

breakdown products of ADPr or ADP-ribosylated species that can be used to trace the
ADP-ribosylated peptides.15, 17 In a second approach, tryptic fragments containing ADPr
moieties were specifically enriched using a TiO2 affinity matrix before MS analysis.
Here we describe a two-step strategy, in the first step enriching and identifying
potentially ADP-ribosylated proteins and in the second step identifying the sites of
modification by a combination of LC-MS and LC-MS/MS experiments.18
As an attractive alternative to the above-described techniques, capillary
electrophoresis (CE) can be utilized in the analysis of ADP-ribosylation due to its
exceptionally high separation efficiency. Easy automation and simple instrumentation
circumvent the labor-intensive work required for SDS-PAGE. Furthermore, owing to
effective dissipation of heat as a result of high surface-area-to-volume ratio, much higher
separation voltages can be used in CE, in contrast to 1-GE and 2-DE. “Clean” buffer
environment used in CE is also advantageous over the radiolabelling approach.
Compared to conventional chromatographic methods, the separation efficiency of CE can
be extremely high for large biomolecules such as proteins, as longitudinal diffusion
ideally the predominant contributor to peak broadening in CE is relatively low. In a
recent finding, a conjecture was proposed that human ARTD-10 (hARTD-10) appeared
to exhibit auto-modification activity and also seemed to modify CK2-alpha, supported by
the observations of sample band shifts in GE for both cases (Appendix E). Moreover,
there was possibility that such auto-modification might in turn affect its catalytic activity.
To shed light on this plausible modification in terms of biological function, the
identification of targets and modification sites is also necessitated. These as a whole led
to a strong research interest and also contributed to our collaboration with Dr. Brian
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Shilton (the Department of Biochemistry, Western University) in joint efforts to explore
an alternative analytical tool for better separation and characterization of the supposed
mono-ADP-ribosylated ARTD-10 and its unmodified counterpart.

In addition to

separation efficiency, CE provides an unrivalled selectivity with regards to the separation
of complex mixtures of closely related proteins, differing only slightly in their primary
sequence, in their PTMs or merely in their conformational state.19 The purpose of this
study is thus to take advantage of the outstanding separation power and selectivity of CE
to develop an optimized CE separation mode for ARTD-10 and its potential mono-ADPribosylated counterpart, in an attempt to elucidate the biochemical activity of ARTD-10.

2.2

Experimental Section

2.2.1

Apparatus
All CE-related experiments were performed on an Agilent 3D-CE (Palo Alto, CA,

USA) instrument equipped with a direct UV-Vis absorbance detector at 254 nm for
mesityl oxide (as neutral EOF marker) and 200 or 214 nm for peptides and proteins.
Untreated fused silica capillaries were purchased from Polymicro Technologies (Phoenix,
AZ, USA) with an inner diameter (i.d.) as 50 µm and an outer diameter (o.d.) as 364 µm.
A 0.25-cm section of the polyimide coating was burned off by electrical heating for oncolumn detection, giving a total capillary length of 48.5 cm with the effective length 40.0
cm to the detection window. In all experiments the capillary cassette was thermostated at
25 °C if not stated otherwise. Data acquisition was carried out on a Pentium II HP
personal computer running HP

3D

CE ChemStation Software by Agilent. MS data were

obtained using a Bruker Reflex IV MALDI-TOF mass spectrometer (Bremen/Leipzig,
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Germany). The instrument was equipped with a 3 ns 337 nm nitrogen laser. Linear
positive ion mode was used for large proteins. Igor Pro (WaveMetrics, Lake Oswego,
OR USA) was used for data processing and presentation for both MS and CE data.

2.2.2

Chemicals and Reagents
All solutions were prepared in Millipore Water Purification System (Barnstead,

Chicago, IL).

Buffers were prepared from reagent grade glacial acetic acid and

ammonium hydroxide (EM Science, Gibbstown, NJ, USA). Double-chain surfactant
didodecyldimethylammonium bromide (DDAB) was purchased from Sigma Aldrich.
DDAB aqueous solution was prepared by dissolving the reagent in Millipore water at a
concentration of 0.1 mM.

The use of the phospholipids 1,2-dilauroyl-sn-

phosphatidylcholine (DLPC) capillary wall coating was accomplished by flushing with
0.1 mM DLPC and 20 mM CaCl2 in 20 mM Tris-HCl, pH 7.4, buffer for 20 min. Mesityl
oxide (MO; Aldrich) was used as a neutral marker for EOF measurements. Lithium
hydroxide and acetic acid (Aldrich) were used for buffer preparation. Dithiothreitol
(DTT; Sigma) was used as a reducing agent. α-Cyano-4-hydroxy-cinnamic acid (CHCA;
Sigma) was purified in ethanol according to the recrystallization procedure of Sigma.
Trifluoroacetic acid (TFA), HPLC-grade methanol, ethanol, and acetone used in the
CHCA matrix preparation were purchased from Fischer Scientific (Hampton, NH, USA).
The analyte of interest in this study, the catalytic domain of ARTD-10 (ARTD-10 cat),
was isolated and purified by our collaborator Dr. Brian Shilton from the Department of
Biochemistry, Western University.
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2.2.3

Capillary Pre-conditioning
Prior to first use, each fresh capillary was preconditioned by flushing (rinsing

with high pressure, 1 bar) with 0.1 M HCl for 10 min, followed by Millipore water for 5
min, 0.1 M NaOH for 10 min, followed by Millipore water for 5 min and then running
buffer for 10 min. DDAB coating was then formed by flushing the capillary with the
surfactant solution for 20 min followed by another 10 min of buffer rinsing to flush out
the excess surfactant. An additional 10 min voltage application to improve coating
stability and repeatability is desirous.20 In-between runs coatings get replenished and
regenerated by a short-time flush of surfactant solution followed by a 2 min buffer rinse.
For used capillaries, preconditioning at the beginning of each day is necessary to remove
any unwanted impurity left before.
EOF measurements were performed by injecting a small plug (20 mbar for 3 s) of
20 mM mesityl oxide (MO) into the capillary followed by a certain period of voltage
application. The CE experimental procedures are stated as follows, if not specified
elsewhere. Samples dissolved in water were introduced hydrodynamically (50 mbar for 6
s), followed by an applied voltage of -20 kV. The detection wavelengths were 200 and
280 nm for EOF marker (MO) and protein samples, respectively.

2.3 Results and Discussions
2.3.1

Optimization of CE Separation Conditions
From the analytical point of view, CE is regarded as a high-performance

separation method because of differentiated electrophoretic migration of ions and
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electrically charged particles on the basis of their charge-to-size ratio.

In order to

optimize the separation of ARTD-10 cat and its modified counterpart, firstly we have to
take a look at their structural differences. Because of the negative charges resulting from
the pyrophosphate group in the ADPr structure, the mono-ADP-ribosylated form of
ARTD-10 cat is expected to have less positive total net charges compared to the
unmodified form. According to the amino acid sequence of ARTD-10 cat provided by
Dr. Brian Shilton, the total net charge of the unmodified form was able to be calculated.
Considered as an ionizable “side chain” of the acceptor amino acid residue, the net
charge contributed by pyrophosphate at a given pH could be calculated using the
equation as follows,

Equation 2.1
where pKa values of pyrophosphate were known to be pKa1 = 0.91 and pKa2 =
2.10 respectively. Hence, we were able to calculate the total net charge of both the
unmodified and the mono-ADP-ribosylated forms of ARTD-10 cat and obtain the plot of
pH vs. calculated charge for ARTD-10 cat and its ADP-ribosylated form (Figure 2.2)
(raw data for the plot available in Appendix B). As discussed before, the total net charge
would then affect the µe values of the analytes. Models that determine the optimum pH
for separation by modeling µe as a function of pH were presented in previous works in
literature, with excellent agreement between theoretical and observed behavior.21
Therefore, through modeling different µe (or migration time) as a function of different pH
values and manipulation of CE conditions to find out a maximum migration time (Tm)
difference, we could achieve optimized separation between the unmodified ARTD-10 cat
and the potential mono-ADP-ribosylated counterpart.
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Figure 2.2 Plot of pH vs. calculated charges for ARTD-10 cat and its mono-ADPribosylated form.

2.3.2

Semi-permanent Capillary Coatings for Prevention of Protein
Adsorption
The attention in CE protein separation has primarily been focused on (i) tuning

the BGE including the buffer type, ionic strength, pH and additives, (ii) tailored postrinse procedures to detach adhered protein residues and (iii) the optimization of capillary
wall shielding in order to reduce protein attachment.19 As discussed in the first chapter,
the effective use of capillary coatings to prevent or minimize protein adsorption is of
essential importance to high-quality protein separations by CE.

ARTD-10 cat, our

analyte of interest, is composed of 217 amino acids with a calculated MW as 24436.5 Da
and theoretical pI ~8.98. For such a basic pI and also relatively large size, the protein
would generally remain positively charged under most of the CE separation conditions
and tend to adsorb onto the fused silica capillary inner surface. Therefore, prevention of
protein adsorption was necessitated prior to any separation. As an attractive alternative to
covalently or permanently coatings, semi-permanent capillary coatings are increasingly
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attractive on account of their analytical efficiency, convenience and simplicity in
operation. In the Yeung lab, the best studied types of semi-permanent coatings include
1,2-dilauroyl-sn-phosphatidylcholine (DLPC) (Figure 2.3 A), sphingomyelin (SM)
(Figure 2.3 B), and didodecyldimethylammonium bromide (DDAB) (Figure 2.3 C).
Compared to single-tailed surfactants, these double-chain surfactants form more stable
bilayers and thus result in more effective shielding of the capillary-wall negative
charges.22-24 Such coatings can be effectively formed and regenerated by simply rinsing
the capillary with the surfactant solution for a short period of time.

A

B

C
B

Figure 2.3 Structures of three double-chain surfactants: (A) DLPC, (B) SM and (C)
DDAB.
The net charge of the surfactant determines the net charge of the resulting
capillary coating, and in turn the direction and magnitude of the resulting EOF. That is,
zwitterionic surfactants DLPC and SM tend to produce a highly suppressed (near-zero)
EOF, whereas DDAB will result in a cationic coating and generate a strong anodic EOF.
The highly stable and strongly reverse EOF obtained in a DDAB-coated capillary allows
rapid and efficient analysis for basic proteins (positively-charged species in acidic
environments) in particular.20, 26, 27 The cationic surfactant DDAB has previously been
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shown to form semi-permanent coatings that effectively prevent adsorption of cationic
proteins in fused silica capillaries with inner diameters of 25–75 mm.25 As a basic
protein with a calculated pI = ~9, ARTD-10 cat would remain positively charged under
acidic conditions. Therefore, DDAB was chosen as the capillary coating in order to
prevent protein adsorption to a maximized extent.

2.3.3

The Choice of Buffering Ions, Ionic Strength and Separation
pH
Optimization of the separation buffer was carried out using a step-by-step

approach due to the few factors involved (i.e., pH and ionic strength). Both pH and ionic
strength influence the protonic equilibrium of ionogenic substances in the electrolyte
solution and that of fixed charged groups on the surface of the capillary wall, affecting
the charge density in the electric double layer and, consequently, the zeta potential. In
addition, the ionic strength influences the thickness of the electric double layer at the
interface between the capillary wall and the electrolyte solution, with the result that,
when the ionic strength increases, the zeta potential and, consequently, the EOF
decrease.28
In general, CE analyses and separations can be influenced by many factors
including pH, buffer concentration (ionic strength), buffer composition (buffering cations,
buffering anions, additives), and the presence of capillary coatings.

Hence, buffer

selection plays an integral role in CE due to its significant effects on EOF, selectivity,
efficiency, resolution and even coating stability.
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Firstly, buffering ions (cation and anion) were determined. For DDAB coating,
buffering anions were found to be a key influencing factor of its stability and analytical
performance. Previous works have been done to prove the reduction of DDAB coating
stability and quality caused by the incorporation of ammonium ions into the BGE. This
is due to the stronger adsorption of ammonium ions (NH4+) onto the negatively charge
capillary wall compared to other metal cations. Therefore, to avoid competition with the
surfactant in the coating procedure, NH4+ ions must be avoided in the buffer.27,

29, 30

Comparing other common metal cations used in CE buffers including lithium (Li+),
sodium (Na+) and potassium (K+), we ended up choosing Li+ as the buffering cation.
This is based on the mobility matching method, namely to reduce electrodispersion
effects and achieve high efficiency by matching the mobility of the BGE co-ions to the
solute mobility. Since ARTD-10 cat is a protein of 24 kDa, a relatively sizable species
with slow CE mobility, in order to obtain mobility matching we should choose the
countercation with low mobility. Showing lower electrophoretic mobility compared to
sodium and potassium, Li+ was therefore selected.

With respect to the choice of

buffering anions, a major criterion was good buffering capacity within the pH range of
choice. Since the cationic DDAB coating favored the analysis of positively charged
analytes, using acidic buffers in which ARTD-10 cat bears a great amount of net positive
charges would be advantageous.

Moreover, to obtain large mobility differences

theoretically between the unmodified and the mono-ADP-ribosylated ARTD-10 cat
shown in Figure 2.2, acidic conditions especially pH 3~5 buffers were preferentially
chosen. As one of the most commonly used CE buffers in this pH range, acetate was
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selected as the buffering anion. In sum, we selected lithium acetate as the CE running
buffer.
Secondly, the effect of buffer concentration (ionic strength) was studied. An
increase of ionic strength in CZE usually results in the decrease in EOF and variable
decreases in the electrophoretic mobility of analytes, which accordingly leads to the
potential for modulating the separation selectivity and resolution by varying the buffer
concentration. On the other hand, the increase of ionic strength also produces higher
current and Joule heating, which is deleterious to CE separation, and therefore ionic
strength increases must be balanced against Joule heating.24 In our experiments, the
concentration of lithium acetate buffer was varied from 10 to 100 mM, and the resulting
capillary electropherograms are shown in Figure 2.4. The results indicated that the
observed peak of ARTD-10 cat (marked with asterisk) became sharpened as the buffer
concentration increased. Since the protein sample only contained minute amount of
acetate, which had a weak UV absorbance at 200 nm, the presence of negative peaks at
higher acetate concentrations (Figure 2.4 A, B) was then caused by the decreased
absorbance of the initial sample plug (carried by the EOF). Namely, the negative peak
can also be regarded as the EOF peak. At low acetate concentrations, no or very small
negative peaks were observed (Figure 2.4 C, D). Instead, significant positive peaks were
observed, which only appeared with the injection of ARTD-10 cat sample, and were thus
attributed to absorbance of impurities in the sample. Also noteworthy is that lowered
peak intensity was obtained with decreased buffer concentration. The reasons accounting
for this observation are deduced to be sample loss caused by increased interactions with
the capillary coating. It has been discussed before that analytes might adhere to the
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capillary wall through electrostatic and hydrophobic interactions in a bare silica capillary,
and coatings serve to shield the negatively charged capillary surface from the samples to
prevent adsorption via electrostatic interaction.

However, hydrophobic interactions

between the samples and the coating still existed and could be promoted by decreased
ionic strength, resulting in peak broadening and reduced intensity at lower buffer
concentration. Overall, 100 mM was determined as the optimal buffer concentration.
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Figure 2.4 Effect of buffer concentration on CE analyses of ARTD-10 cat in a DDABcoated capillary: (A) 100 mM; (B) 50 mM; (C) 20 mM; (D) 10 mM. All protein peaks
are marked with asterisks.

CE conditions: sample concentration at 0.15 mg/mL,

hydrodynamic injection at 50 mbar for 6 s, pH 4.00 lithium acetate buffer, applied
voltage -20 kV.
Thirdly, the effect of buffer pH on the electrophoresis of ARTD-10 cat was
determined. Buffer pH represents one of the most important experimental parameters in
CE by manipulating selectivity in electrophoresis-based separations, since it affects the
degree of ionization and thus the effective mobility of weakly ionic species. As
previously shown in Figure 2.2, ARTD-10 cat bears highly net positive charges at acidic
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pH conditions. Consequently, as the net charge of these proteins becomes increasingly
positive with exposure to the increased acidity, there is more adsorption on the fused
silica capillary surface. However, such strong cationic character is still favorable in
avoiding protein adsorption in the presence of the cationic DDAB coating. The pH of
100 mM lithium acetate buffer was varied from pH 3.00 to pH 5.00, and the resulting
capillary electropherograms are shown in Figure 2.5. The results indicated that the
observed peak of ARTD-10 cat (marked with asterisk) became sharpened as the buffer
pH was lowered. A sharp protein peak was obtained from 100 mM pH 3.00 lithium
acetate (Figure 2.5 A), with calculated efficiency as 1,060,000 plate/m. However, it is
worthwhile to mention the occurrence of a doubly-split peak at pH 5.00 (Figure 2.5 C)
herein, possibly caused by poor sample quality, conformational change under less acidic
conditions or the existence of subspecies. Also, the analysis of certain proteins can
possibly show numerous challenging properties, e.g. self-aggregation, limited solubility
and pH stability, strong adsorption to the coating, and other. To test the sample purity,
MALDI MS experiments were performed on the ARTD-10 cat sample. No suspicious
peaks were observed in the resulting mass spectra (data not shown), clearly showing [M
+ H]+ peak (m/z 24250) [M + 2H]2+ peak (m/z 12130) and [M + 3H]3+ peak (m/z 8086)
as the major sample peaks. In this sense, we were not able to conclude the reasons for the
observed peak splitting, and further investigations would be required. Also noteworthy is
the lowered peak intensity obtained under less acidic conditions, which could possibly be
attributed to protein adsorption. Overall, pH 3.00 was chosen as the separation pH due to
highest peak efficiency observed. To sum up, 100 mM pH 3.00 lithium acetate was
determined as our optimal CE conditions.
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Figure 2.5 Effect of pH on CE analyses of ARTD-10 cat in a DDAB-coated capillary:
(A) pH 3.00; (B) pH 4.00; (C) pH 5.00. All protein peaks are marked with asterisk. CE
conditions: sample concentration at 0.15 mg/mL, hydrodynamic injection at 50 mbar for
6 s, 100 mM lithium acetate buffer, applied voltage -20 kV.
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2.3.4

CE Analysis of ARTD-10 cat
In this section, the results of several CE analyses of ADP-ribosylation

modification on ARTD-10 cat will be presented.

Two in-vial ADP-ribosylation

modification experiments were individually carried out by Dr. Brian Shilton on Jun 2nd
and Jun 3rd in 2011, referred to as ADP-ribosylation 1 and ADP-ribosylation 2 in this
report (Table 2.1). The objective of this experiment was compare the CE migration time
of the observed major protein peaks between the unmodified and the proposed ADPribosylated ARTD-10 cat samples. To provide further confirmation, two negative control
experiments were performed in the meantime.

In the first negative control, 3-

aminobenzaminde (3-AB) was added together with NAD+ (+inhibitor), while the second
control was prepared in the absence of NAD+ (–NAD+). 3-AB acts as an effective
inhibitor of PARPs, due to its benzamide structure that resembles NAD+ and interferes
with NAD+-consuming PARP enzymes.31
The untreated ARTD-10 cat, the negative control samples and the treated samples
were then subject to CE analysis. A series of capillary electropherograms were obtained
and they are shown in Figure 2.6. The characteristic UV profile of proteins, namely the
strong absorbance of peptide bonds in proteins at around 200 nm in the far UV spectrum,
could assist in protein identification.32 Based on the same UV absorbance patterns, we
were able to distinguish the ARTD-10 cat peaks (labelled with asterisks) in Figure 2.6
B~D from the multiple peaks possibly caused by other reagents.
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Table 2.1 Composition of the ADP-ribosylation reaction mixtures.

1 M HEPES, pH 7
80% glycerol
1 M MgCl2
0.5 M DTT
40 mM NAD+
100 mM
aminobenzaminde
water
ARTD-10 cat, ~5
mg/mL in 50 mM
pH 4.5 AmAc

(A)
untreated
ARTD-10
cat
-

(B) control 1
(+ inhibitor)

(C)
control 2
(–NAD+)

(D) ADPribosylation
1

(E) ADPribosylation
2

20 µL
40 µL
2 µL
4 µL
25 µL

20 µL
40 µL
2 µL
4 µL
-

20 µL
40 µL
2 µL
4 µL
25 µL

20 µL
40 µL
2 µL
4 µL
25 µL

-

20 µL

-

-

-

150 µL

39 µL

84 µL

59 µL

59 µL

50 µL

50 µL

50 µL

50 µL

50 µL
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Figure 2.6 Capillary electropherograms of ADP-ribosylation modification experiments:
(A) untreated ARTD-10 cat; (B) negative control 1 (+inhibitor); (C) negative control 2 (–
NAD+); (D) treated sample 1; (E) treated sample 2. All protein peaks are marked with
asterisks. CE conditions: 100 mM pH 3.00 lithium acetate, hydrodynamic injection at 50
mbar for 6 s, applied voltage -20 kV.
Comparing the capillary electropherograms collected for the untreated ARTD-10
cat (Figure 2.6 A; Tm = 2.00 min) with the treated sample 1 (Figure 2.6 D; Tm = 2.27
min) and the treated sample 2 (Figure 2.6 E; Tm = 2.16 min), shifts in the protein
migration time (Tm) were observed. Such Tm difference could be potentially caused by
ADP-ribosylation modification. However, CE results obtained from the two negative
controls were rather ambiguous and conflicting. There was no expectation for any shifts
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in either of the controls (Figure 2.6 D and Figure 2.6 E, compared to Figure 2.6 A), a
shift was detected in the negative control 1 (+ inhibitor) (Figure 2.6 B; Tm = 2.23 min).
It is noteworthy that the within-day (using the same capillary and buffers)
migration time generally showed good reproducibility for three consecutive runs, with
relative standard deviation (RSD) less than 1%. Hence, two possibilities could be elicited
accounting for the conflicting data: (i) the inhibitory effect of 3-AB was invalid; (ii) the
Tm shift observed was not related to ADP-ribosylation; e.g., the untreated ARTD-10 cat
interacted with at least one of the component in the reaction mixtures and resulted in
mobility change. In either event, one cannot unambiguously conclude the Tm shifts
observed in Figure 2.6 resulted from ADP-ribosylation modification. In addition, the
peaks observed additional to ARTD-10 cat had not been identified. We decided to
perform additional experiments to investigate whether the Tm shifts resulted from ADPribosylation and to assign the multiple peaks presented.

2.3.5

Investigations into Effects of Different Reagents in ADPribosylation Reaction Mixtures
In this section, we conducted several CE analyses to determine the possible Tm

shifts caused by other reagents in the ADP-ribosylation reaction mixtures. This would
hopefully provide some insights into the cause of the Tm shifts to confirm whether they
resulted from ADP-ribosylation or not. More specifically, the reagents (including DTT,
MgCl2, glycerol, HEPES and NAD+; further information available in Appendix C)
required to perform ADP-ribosylation modification reaction were individually injected
with the untreated ARTD-10 cat followed by CE analysis.

The resulting capillary
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electropherograms were shown in Figure 2.7. Noteworthy is the slightly slower EOF
observed in this set of experiments compared to that in Figure 2.6. Generally, such
minor EOF variation is normal in CE. No reagent was found to produce complicated
background peaks.
To sum up, all of these reagents were either undetectable at 200 nm, or detected as
neutral/near-neutral molecules in this set of experiments. Importantly, this observation
did not account for the multiple peaks observed between 1.8–2.2 minutes in Figure 2.7 B,
Figure 2.7 D and Figure 2.7 E. Finally, the reaction mixture for ADP-ribosylation was
prepared by adding all the reagents at the same time without incubation and analyzed.
Compared to Figure 2.7, the resulting capillary electropherograms (data not shown) did
not display patterns of multiple peaks, showing double peaks at most.

We could

therefore speculate that there might be unknown interactions that created those peaks,
such as NAD+ degradation and cross-reaction.
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Figure 2.7 Effects of different components on CE migration time of ARTD-10 cat: (A)
untreated ARTD-10 cat; (B) ARTD-10 cat in 5 mM NAD+; (C) ARTD-10 cat in 16%
glycerol; (D) ARTD-10 cat in 2 mM DTT; (E) ARTD-10 cat in 100 mM HEPES; (F)
ARTD-10 cat in 10 mM MgCl2. All protein peaks are marked with asterisks. CE
conditions: sample concentration at 0.15 mg/mL, 100 mM pH 3.00 lithium acetate,
hydrodynamic injection at 50 mbar for 6 s, applied voltage -20 kV.
Secondly, the possible effect of each component on the Tm shifts of ARTD-10 cat
can also be reflected in Figure 2.7. The potential effects of these component reagents
included increased buffer viscosity (glycerol), increased ionic strength or conductivity
(MgCl2), unexpected reaction with (NAD+ or DTT) and changed buffer pH (HEPES).
However, the additions of NAD+, glycerol, DTT, HEPES and MgCl2 did not result in
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obvious change in the Tm of ARTD-10 cat peak. The data collected so far were not able
to effectively explain the cause of peak shifts. That is, the effects of different reagents on
the protein Tm shifts still remained unclear at least for the current CE conditions.
Therefore, continued investigation into the cause of the observed peak shifts was
necessary.

2.3.6

Continued Investigation into the Cause of Protein Migration
Time Shifts
Up until this point, no direct experimental evidence proved ADP-ribosylation of

ARTD-10 cat resulted in Tm change in CE analyses conducted at pH 3. This is a
challenging task to achieve due to: (i) the mono-ADP-ribosylation of ARTD-10 cat has
not been confirmed by other methods; and (ii) there is no prior knowledge on whether the
charge difference resulted from ADP-ribosylation of ARTD 10 cat is sufficient to cause a
detectable peak shift in CE migration time at specific conditions. As mentioned above,
the charge difference between the modified and unmodified ARTD-10 cat (Figure 2.2)
was based on the ionization of pyrophosphate, and thus it is justifiable to suspect the
actually net charge may differ from the predicted value calculated by the pKa values.
Naturally, the next step was to repeat the CE runs using higher pH buffers, to vary
ionization of pyrophosphate on the mono-ADP-ribosylated ARTD-10 cat, if there was
any.
Using 100 mM pH 5.00 lithum acetate as BGE, it was evident that the Tm shift
observed for the treated sample became more apparent (Figure 2.8 A) compared to the
untreated one (Figure 2.8 B). To continue the previous investigation on the cause of
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these peak shifts, the reagents were again added separately to the untreated ARTD-10 cat
for individual CE analysis. This resulted in another set of capillary electropherograms, in
which DTT was found to greatly shift the Tm (data not shown). Therefore, we performed
a control experiment to confirm the effect of DTT, in which ARTD-10 cat was incubated
with 2 mM DTT for 12 h at room temperature followed by CE analysis. The same
pattern of peak shift was observed with the addition of DTT and in both cases, a peak
with totally different Tm was detected (Figure 2.8 C). One possibility accounting for this
is that the protein became less positively charged under less acidic conditions and
protein-wall adsorption began to occur despite of the DDAB coating. However, the
presence of DTT somehow interfered with this adsorption, and resulted in a peak shift.
Another possibility is that the protein-DTT interaction resulted in an unidentified cationic
species with distinctly different Tm value compared to the untreated ARTD-10 cat. Yet
we were not able to drive at a final conclusion without further investigations. Above all,
it was confirmed that interactions between DTT and ARTD-10 cat were responsible for
the observed Tm shifts in the capillary electropherograms.
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Figure 2.8 Capillary electropherograms for examining the effect of DTT on ARTD-10
cat: (A) treated ARTD-10 cat; (B) untreated ARTD-10 cat; (C) the incubation mixture of
ARTD-10 cat with 2 mM DTT. CE conditions: sample concentration at 0.15 mg/mL,
100 mM pH 5.00 lithium acetate, hydrodynamic injection at 50 mbar for 15 s, applied
voltage -20 kV.
To take one step further, we turned to gel electrophoresis (GE) for confirmation.
Reducing GE is commonly used to further denature proteins by reducing disulfide
linkages, thus overcoming some forms of tertiary protein folding, and breaking up
quaternary protein structure (oligomeric subunits) in the presence of a reducing agent
such as DTT and beta-mercaptoethanol (BME).

In addition to reducing GE, non-
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reducing GE is normally used when native structure is important for further analysis.
Firstly we applied: (i) untreated ARTD-10 cat (both the one for CE analysis and the stock
protein solution in the Shilton Lab), (ii) negative control 2 (–NAD+) as well as (iii) the invial incubation mixture of DTT and ARTD-10 cat, on a non-reducing gel, which showed
us four other bands (A~D) on the left side of the figure in Appendix F. Similar sample
band shifts compared to that of the untreated protein were detected in both of the
circumstances, suggesting the effect of DTT on the mobility change. Therefore, we
arrived at the assumption that inter-molecular disulfide linkages existed in ARTD-10 cat
and DTT acted as a reducing agent.

It was equally possible that DTT had other

unidentified interactions with the analyte to cause conformational change and/or
slowdown in mobility.
To underpin our hypothesis with further evidence and understand the possible
DTT-sample interactions, experiments on reducing GE using BME as a reducing agent
were also conducted. Likewise, we applied: (i) untreated ARTD-10 cat (both the one for
CE analysis and the stock protein solution in the Shilton lab), as well as (ii) negative
control 2 (–NAD+) and (iii) treated ARTD-10 cat sample 2, on a reducing gel, which
gave us the five bands (E~I) on the right side of the figure in Appendix F. Exactly the
same shifting patterns of all the sample bands including the untreated ARTD-10 cat band
were observed. To sum up, DTT’s effect on ARTD-10 cat was confirmed by CE and
non-reducing GE, and was revealed to be the reduction of disulfide bond by reducing GE.
The existence of disulfide bridge(s) in ARTD-10 cat therefore confirmed, yet further
investigation has to be carried out to find out the number of disulfide bonds as well as to
characterize their sites.
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Last but not least, the band upshifts observed in non-reducing GE resulting from
the addition of DTT, were once postulated to be an indication of auto-modification in a
master thesis from our colleagues in Germany.

It was thereby believed that their

conclusion was incorrect due to the omission of DTT’s effect (further reading available in
Appendix D and Appendix E). The sequence for ARTD-10 cat provided by Dr. Brian
Shilton is as follows (possible disulfide-formation sites on cysteine are labeled in red
color; possible cleavage sites by trypsin digestion treatment on arginine and lysine are
underlined):
MAGQTLKGPW

NNLERLAENT

GEFQEVVRAF

YDTLDAARSS

IRVVRVERVS

HPLLQQQYEL

YRERLLQRCE

RRPVEQVLYH

GTTAPAVPDI

CAHGFNRSFC

GRNATVYGKG

VYFARRASLS

VQDRYSPPNA

DGHKAVFVAR

VLTGDYGQGR

RGLRAPPLRG

PGHVLLRYDS

AVDCICQPSI

FVIFHDTQAL

PTHLITCEHV

PRASPDDPSG

AHHHHHH

It is, therefore, justifiable to assume the potential explanation for the interaction
between ARTD-10 cat and the reducing agents (DTT and BME) is the breakage of the
disulfide linkage, which is yet to be confirmed by several approaches such as MS
analysis subsequent to tryptic digestion.

2.3.7

MALDI MS Analysis of ADP-ribosylation
Mono-ADP-ribosylation of peptides and proteins is calculated to yield a 541.1 Da

(the net mass gain resulting from the attachment of ADPr) increase in the monoisotopic
mass of peptides and a 541.3 Da increment in the average mass of full-length proteins.33
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Theoretically, the calculated MW for ARTD-10 cat is 24436.5 Da, leading to 24977.8 Da
for that of the mono-ADP-ribosylated form. For such a big modification, MALDI MS is
theoretically capable of discriminating between the modified and the unmodified form
judged by a large difference in m/z values.
MS analysis may suffer from endogenous compounds in the form of ion
suppression: a form of matrix effect that negatively influences the sensitivity of the mass
spectrometric detection. Therefore, it is necessary to perform sample clean-up or pretreatment prior to MS analysis especially for sample from complicated biological sources.
Therefore, prior to MALDI MS identification, the samples may also need to be desalted
and concentrated, and this is most frequently accomplished by using commercially
available reverse phase C18/C4 Ziptip (pipette tips containing C18 or C4 resin).
Therefore, in order to obtain a better MS signal, we referred to Ziptip micropipette
desalting techniques. ZipTip C4 tips are appropriate for proteins of low to intermediate
MW, proteins over 100,000 Da, which is exactly the case for the analysis of ARTD-10
cat protein. The C4-Ziptip-desalted treated and untreated (with in vitro mono-ADPribosylation attempts) ARTD-10 cat samples were applied to MALDI MS analysis
individually, and the resulting mass spectra are shown in Figure 2.9. By comparison of
the major peaks between the treated and the untreated protein samples, the selected [M +
H]+ and [M + 2H]2+ peaks displayed almost the same m/z profiles, showing no indication
of modification. Noteworthy is the experimentally obtained MS of ARTD-10 cat was
approximated 200 Da smaller than the theoretical one, which required further
biochemical studies to explain.
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Figure 2.9 MALDI mass spectra of C4 Ziptip-desalted ARTD-10 cat samples: (A)
negative control 2 (–NAD+); (B) treated ARTD-10 cat 2.

2.4

Conclusions
CE takes an active part in current analytical field especially for studies on

biomolecules, contributed by its versatility in and distinguished performance in
conventional analyses. There is an extensive body of literature on PARP recent years,
among which CE-related publications have not been reported. This study has been
undertaken to present efforts toward CE studies of ADP-ribosylation modification. The
MALDI-MS data was also a good supplement to our evidence, denoting no sign of ADPribosylation modification on the sample.

Collectively, these data indicate that the

attempts for ADP-ribosylating ARTD-10 were not successful. We also confirmed that
DTT was accounted for both Tm differences in CE and band shifts in GE, which were
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resulted from reduction of the disulfide bridge(s) in ARTD-10 cat. However, there
existed some observations that could not been explained so far, such as the double peak
of ARTD-10 cat presented at pH higher than 5 and the observed 200 Da smaller MW in
MS compared to the theoretical MW. This work has brought some light on the analysis
of ARTD-10, yet a substantial amount of work has to be done to fully resolve the PARP
biochemistry. Further validation of the interactions between DTT and ARTD-10, most
possibly disulfide linkages, is necessitated to acquire a conclusive remark.
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Chapter 3.

In-Capillary Derivatization: Miniaturized
Methyl Esterification of Phosphopeptides
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3.1

Introduction
As one of the most significant and prevalent protein PTMs, reversible protein

phosphorylation plays a crucial role in a broad range of biological functions including
modulation of enzymatic activity, subcellular localization, intra- and inter-molecular
protein interactions, and also cellular processes such as intracellular signal transduction,
cell differentiation and progression through the cell cycle.1 The analysis of protein
phosphorylations, however, is not a straightforward process.

Detection of

phosphopeptides and characterization of single or multiple phosphorylation sites of
phosphoproteins poses challenges for instrumental techniques, along with several
complications needed to be addressed. In the complex cellular milieu, phosphoproteins
are present in very low copy numbers, and only a small fraction of any given protein is
phosphorylated at any given time. Moreover, specific phosphorylated sites on a protein
may vary and/or can be only partially phosphorylated.
As a main-stream technique for unbiased protein analysis in particular the
characterization of protein PTMs, mass spectrometry (MS) is routinely utilized for the
identification of protein phosphorylation especially for the large-scale study of protein
phosphorylation, i.e. phosphoproteomics. Nonetheless, mass spectrometric identification
of phosphorylated peptides and proteins is relatively challenging due to their low
abundances, incomplete peptide coverage of the proteolytically cleaved proteins as well
as suppressed ionization in the presence of other non-phosphorylated peptides in high
abundances. Also, phosphorylated peptides with low stoichiometric levels for a given
protein are therefore overshadowed by their unmodified counterparts. Phosphopeptide
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detection suffers from low relative ionization efficiency in positive ion mode and
generally lower sensitivity in the negative ion mode.

Hence, developing new MS-

compatible methods for the enrichment and isolation of phosphopeptides from complex
mixtures aimed at the assignment of phosphorylation sites remains to be a key issue for
many research groups worldwide.

Significant advances in both phosphopeptide

enrichment methods and sensitive MS instrumentation have been achieved over the past
decade to facilitate the progressing of phosphoproteomics.

Mainstream strategies

encompass physical fractionation of tryptic digest of complex peptide mixtures by strong
cation exchange (SCX) chromatography; phosphopeptide enrichment by metal oxide
affinity chromatography (MOAC), immobilized metal ion affinity chromatography
(IMAC), or the use of chemistry-based derivatization strategies to introduce stable
affinity tags on the phosphate groups. Among all the affinity-based methods, IMAC has
proven very successful in providing near complete enrichment of phosphorylated
peptides and contributes largely to the success of proteome-wide profiling of
phosphoproteins.2
Recent developments for MS-based phosphoproteomics highlight an area of
considerable interest: the introduction of suitable derivatization procedures to increase
detection sensitivity, to promote sample ionization and hence the detection of
phosphorylated peptides, or even to increase the information content of a fragment
spectrum. As a common derivatization strategy, methyl esterification has been applied to
peptide and protein quantitation, de novo sequencing and reducing non-specific binding
of acidic amino acid residues prior to IMAC for enrichment of phosphorylated peptides.3
Methyl esterification of a peptide converts carboxylic acids, such as those present on the
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side chains of acidic amino acid residues aspartic acid, glutamic acid as well as the free
carboxyl terminus (C-term), to their corresponding methyl esters in the presence of a
suitable acidic catalyst, as illustrated in Figure 3.1.

Figure 3.1 General reaction scheme of methyl esterification; the top reaction shows the
formation of anhydrous MeOH-HCl; the bottom reaction shows the methyl esterification
of free carboxyl groups.
where methanolic hydrochloride (MeOH-HCl; hydrochloric acid in anhydrous
methanol) is prepared as both an esterifying agent and an acidic catalyst. In addition to
improving MS/MS fragmentation efficiency and sequence coverage, the conversion of
peptide carboxylates to their corresponding methyl esters has been shown to sharply
reduce non-specific binding in IMAC towards acidic peptides, enhancing the selectivity
for phosphopeptides.3, 4 Notably, methyl esterification has been used in previous studies
to increase specificity for the selective detection of phosphopeptides in negative ion mode
by hybrid quadrupole time-of-flight (Q-TOF) MALDI MS.5
Advanced bioanalytical techniques require appropriate analytical protocols with
adequate sensitivity and selectivity, and meanwhile minimize sample or reagent
consumption.

With this in mind, it is highly appreciated to develop miniaturized

analytical and sample processing systems.6

Microreactors, which are referred to

miniaturized reaction systems in which chemical reactions take place in fluid channels,
facilitate the conduction of chemical processes with volumes typically in the sub-micro-
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to sub-milliliter range. The major requirements for microreactors include (i) easy and
reproducible mixing, (ii) negligible evaporation, and (iii) simple interfacing with
sensitive and informative analytical tools.7

A capillary or a narrow channel could

therefore serve as an attractive medium for performing miniaturized reactions, acting as
not only a microreactor for carrying out a reaction at sub-microliter (sub-µL) or nanoliter
(nL) levels but also a separation column to fractionate the analytes prior to subsequent
analysis.8 The interfacing of microfluidic devices such as CE with MS detection therefore
attracts broad attention in the recent development of the phosphoproteomics.
Performing the in-capillary methyl esterification reaction presents the advantages
of low sample and reagent consumption, aiding in the miniaturization of the reaction.9
The work presented here aims to investigate and hopefully resolve a number of
challenges associated with in-capillary methyl esterification. The first challenge is the
extremely acidic reaction conditions which can potentially damage the instrument
components. The second one is that the reaction must be performed in a water-free
environment, in the light of the reversibility of the reaction in the presence of water. As a
traditional approach to manipulate the capillary wall charge, capillary coatings, however,
are typically sensitive to organic solvents and very likely to be seriously damaged in the
presence of methanol used in common methyl esterification method.

Hereby,

preliminary efforts towards in-capillary methyl esterification of phosphorylated peptides
for MALDI MS analysis along with on-capillary-tip sample recovery after removal of
unfavorable organic solvents were presented, in an attempt to develop subsequent incapillary recapture and enrichment of target molecules by means of either dynamic pH
junction or solid phase extraction using immobilized magnetic beads.
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3.2

Experimental Section

3.2.1

Apparatus
All CE-related experiments were performed with an Agilent 3D-CE Capillary

Electrophoresis Instrument (Palo Alto, CA, USA). Uncoated fused-silica capillaries were
purchased from Polymicro Technologies (Phoenix, AZ, USA). The capillary dimensions
were 50 µm in inner diameter, 360 µm in outer diameter with a total length of 48.5 cm.
MALDI mass spectrometric data was obtained using the following two
instruments. A 4700 Proteomic Discovery System MALDI TOF/TOF MS (Applied
Biosystems, Farmingham, MA) was used to perform MS analyses for the experiments on
β-casein tryptic digest.

The instrument is equipped with a 355-nm Nd:Yag laser.

Reflectron and positive ion mode were chosen for the detection of peptides. All voltage
settings were left at the default values preset by Applied Biosystems. Peptides were
acquired over the range m/z 500–3500. Mass spectra were recorded as sums of 1000
shots under video monitoring in all experiments, if not specified elsewhere.
A Bruker Reflex IV MALDI-TOF MS (Bremen/Leipzig, Germany) was also used
to perform MS analyses on the methyl esterified β-casein tryptic digest. The instrument
is equipped with a 337-nm nitrogen laser. Reflectron mode was used for the detection of
peptides with both positive and negative ion modes. All voltage settings were left at the
default values preset by Bruker. Mass spectra were recorded as sums of 100 shots under
video monitoring in all experiments, if not specified elsewhere.

Calibration was

conducted using standard peptide mixtures. Peptides were acquired over the range m/z
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500–3500.

Igor Pro (WaveMetrics, Lake Oswego, OR, USA) was used for data

processing.

3.2.2

Chemicals and Reagents
Anhydrous methanol was purchased from Sigma Aldrich (St. Louis, MO, USA)

and was used in capillary preconditioning and methyl esterification reactions. Acetyl
chloride was purchased from Fluka and was used as a source of protons in the methyl
esterification reaction. For the initial experiments a model peptide was chosen instead of
using a phosphorylated protein digest.

Angiotensin I (AI) and angiotensin II (AII)

(Sigma Aldrich) were selected as model peptides due to low cost and the presence of two
possible sites of methyl esterification. Monophosphorylated peptide was obtained from
tryptic digestion of β-casein from bovine milk (Sigma Aldrich) with sequencing grade
modified trypsin (Promega, Madison, WI). The tryptic digestion was performed at the
volume of 1 mL with 1 mg of β-casein from bovine milk and 20 μg trypsin at an enzymeto-substrate ratio of 1:50 (w/w) in 50 mM pH 8 ammonium bicarbonate and 2 mM
calcium chloride and set overnight at 37 °C. After digestion, TFA was added into the
sample solution at 1% to quench the reaction and the resulting solution was then
lyophilized to dryness, diluted in water at a 2 mg/mL concentration, and stored in the
freezer (-20 °C). Deionized water was obtained from a Millipore purification system
(Bedford, MA, USA). α-Cyano-4-hydroxy-cinnamic acid (CHCA; Sigma) was chosen as
the MALDI matrix and purified in ethanol according to the recrystallization procedure of
Sigma. Trifluoroacetic acid (TFA), HPLC-grade methanol, ethanol, and acetone used in
the CHCA matrix preparation were purchased from Fischer Scientific (Hampton, NH,
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USA). Diammonium citrate was included in the CHCA matrix due to previous discovery
that it can contribute to more complete peptide mapping coverage of the casein sequence
and also enhanced signal response of the phosphorylated peptides.10 The 2 M methanolic
hydrochloride (MeOH-HCl) solution was freshly prepared by dropwise addition of 160
μL of acetyl chloride, while stirring under a ventilation hood, to 1 mL of anhydrous
methanol.

3.2.3

Capillary Preconditioning
Prior to use, a new capillary was flushed (1 bar) with anhydrous methanol for 30

min. It is indispensable that all water from the peptide solutions be removed prior to the
addition of the esterification reagent to obtain complete conversion of carboxylic groups
to methyl esters and reduce side products. In other words, a water-free environment is
crucial to the successful conversion of a peptide to its corresponding methyl ester. As a
consequence, the typical capillary pre-treatment of flushing the capillary with aqueous
solutions was not employed. Between runs, the capillary was flushed with anhydrous
methanol for at least 30 min. After use, the capillary was flushed with anhydrous
methanol for 30 min and stored with the ends of the capillary in vials of methanol.

3.2.4

Methyl Esterification

3.2.4.1

In-Vial Methyl Esterification

To selectively convert carboxylate groups of peptides to methyl esters, 2 M
MeOH-HCl solution was prepared following a well-established literature protocol
developed by Ficarro et al.11 In short, 160 µL of acetyl chloride was added drop-wise to
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1 mL of anhydrous methanol. Due to the large amount of heat generated, the reagent was
then allowed to sit for 5 min at room temperature before being used. This formula can
either be scaled up or downsized according to different requirements, as long as the same
acetyl chloride to anhydrous methanol ratio is maintained. Fresh solutions of MeOH-HCl
were prepared for each day’s use.
In-vial reactions were performed by direct addition of MeOH-HCl to a 0.6 mL
PCR vial containing dried (by SpeedVac, a centrifugal vacuum concentrator) peptides
angiotensin I (AI) and angiotensin II (AII). The vial was capped and reactions were
allowed to proceed for different lengths of time at room temperature. Once the reaction
time was reached, solvent was removed in SpeedVac, and the resulting dried peptides
were redissolved in water. A portion (2 µL) of sample solutions was mixed with 2 µL of
the matrix solution, in a 1:1 (v/v) ratio, and an aliquot of 0.73 µL was spotted onto the
MALDI target and dried at atmospheric pressure, followed by MALDI MS analysis.
Timed experiments were conducted in a similar manner. Dried peptide samples
were resuspended and incubated for variable time periods (20 min, 40 min, 60 min and 2
h) in the presence of 2 M MeOH-HCl at room temperature. The reaction mixtures were
then dried and redissolved in water or other appropriate solvents for subsequent MALDI
MS analysis.

Samples were analyzed by MS to determine the extent of methyl

esterification of acidic groups as a function of time, as well as to identify side products.

3.2.4.2

In-Capillary Mixed Methyl Esterification

The capillary was first flushed with high pressure (1 bar) for 30 min with
anhydrous methanol to remove any trace of water present inside the capillary. In view of
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the strong acidity and erosiveness of the esterification reagents, it is preferential to
perform CE injections from outside the instrument in order to protect the electrodes as
well as the interior parts of the instruments. Noteworthy is that it is recommended to
have the liquid level of the buffer surface in the inlet side at the same height as the tip of
the capillary at the outlet to avoid unwanted siphoning.12 After fresh MeOH-HCl was
prepared, a short plug of peptide dissolved in anhydrous methanol was injected (10 s, 50
mbar) followed by another plug of MeOH-HCl (10 s, 50 mbar). This sequence was
repeated in alternating plugs which were 1 cm long with 10 of each plug for a total of 20
plugs. The reaction was then allowed to proceed for specific time periods. Once the
reaction time was reached, low pressure (50 mbar) was applied to mobilize the capillary
content onto the MALDI target.

3.2.5

MALDI Conditions and Spotting from Capillary
To transfer the sample band from the capillary onto the MALDI sample plate, the

cathodic end of the capillary was repositioned outside the instrument, while the anodic
end remained inside the instrument. Elution of the capillary content was performed by
applying a constant pressure (50 mbar) at the capillary inlet in 20-s intervals, yielding 35
nL fractions which were manually deposited onto the sample plate pre-spotted with
matrix. A schematic of this method is shown in Figure 3.2. Briefly, once the reaction is
complete, the outlet is placed outside the instrument and low pressure was used to
mobilize the product toward the outlet where it was spotted onto the MALDI target. The
DHB was prepared from a literature procedure and applied to the MALDI target in two
layers (0.5 µL base layer, and 0.2 to 0.05 µL top layer, then sample).13
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Table 3.1 Three-layer CHCA sample spotting method.
1st layer

0.5 μL

5 mg/mL CHCA in 4:1 acetone:methanol

2nd layer

0.25 μL

Saturated CHCA in 3:2 water:methanol

3rd layer

35 nL

Sample

Pressure

MALDI MS
Two-layer Matrix Pre-coated

Figure 3.2 Schematic of spotting from outside of the CE instrument.

3.2.6

On-Capillary-Tip Hanging Droplet Reaction
Despite the advantages offered by in-capillary mixing, there remained concerns

about the mixing efficiencies solely by diffusion. Therefore, a new experimental design
taking advantage of the CE instrumental set-up was proposed: immediately after
alternating bands of reactants (peptides and MeOH-HCl) are introduced into the capillary,
high pressure will be applied to flush the capillary contents into a hanging droplet at the
capillary tip to guarantee complete mixing. To be more specific, one end of the capillary
is placed outside of the instrument through the entire process, and the hanging droplet
which contains the anhydrous reagents is kept in a capped vial to maintain the sealed
environment to prevent any water contamination from the open air. Once the reaction
time was reached, the hanging droplet was carefully transferred to a clean PCR tube and
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Speed-vas was used to evaporate the organic solvents, simply to test the degree of
completeness for the esterification by subsequent MALDI MS analysis.

3.2.7

On-Capillary-Tip Droplet Sample Recovery Test
Up until this point, there were well-established methods to perform methyl

esterification inside capillary. Due to the labor-consuming process of recollecting the
hanging droplet back into a vial to enable sample drying, another method can be applied
to facilitate subsequent CE separation and enrichment combined with removal of excess
methanol and HCl. That is, the esterified products can be directly dried at the capillary
tip as a hanging droplet, by the aid of a nitrogen flow. After complete removal of any
remanent solvent, a droplet of buffer was directly pipetted onto the capillary tip and sat
for 30 s, and the peptide recovery would be evaluated in MALDI MS using recovery
buffers of different composition: 50% acetonitrile (ACN), 1% TFA, 10 mM pH 9
ammonium acetate (AmAc), 50% ACN in 10 mM pH 9 AmAc.

3.3

Results and Discussion
Through examination of the derivatization effectiveness and efficiency for three

types of experimental set-up, peptide samples used in this work included angiotensin I
(AI) and angiotensin II (AII) as model peptides, and β-casein tryptic digest as the source
of phosphopeptide. For the sake of convenience, it is necessary to list the data selected
corresponding to different types of methyl esterification attempts as follows.
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Table 3.2 Data chosen for showing the methyl esterification results in this work. Peptide
samples used for conducting methyl esterification derivatization corresponding to types
of experiments are listed.

Methyl Esterification
Attempts

In-Vial

In-Capillary Mixing

1 h Reaction
Time

1 h Reaction
Time

Model peptides
(AI & AII)

✓

✓

β-Casein tryptic digest

✓

3.3.1

Timed
Experiment

On-CapillaryTip
1 h Reaction
Time
✓

✓

Effectiveness of Methyl Esterification

3.3.1.1

In-Vial Reaction

The value of an attractive derivatization approach is affected by the speed and
completeness of the reaction, the occurrence of undesirable byproducts, and ease of
reagent removal.14 High conversion ratio of derivatization reaction remains to be a major
requirement.

This is particularly true when it comes to methyl esterification of

phosphorylated peptide in consideration of reducing the complexity of MS signals.
Therefore, through our initial experiments, the in-vial chemistry of methyl esterification
was tested first using angiotensin I (AI) and angiotensin II (AII) as model peptides.
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Figure 3.3 MALDI mass spectrum of in-vial methyl esterification for AI and AII.
Peptides were at the concentration of 0.05 mg/mL.
After 1 h of incubation, high-abundance peaks were observed with m/z 1074 and
m/z 1324 at as is shown in Figure 3.3. The peptide sequence for AI and AII are
DRVYIHPFH and DRVYIHPF, with calculated monoisotopic peaks [M + H]+ of
1296.48 and 1046.18, respectively. With a mass increment of 14 Da introduced by each
conversion of the carboxyl to its methyl ester, the mass shifts of 28 Da in both derivatized
peptides are thus indicative of the formation of two methyl esters in each peptide: one at
the side chain of D and one at the C-term. Thus, the peaks at m/z 1310 and m/z 1060 are
indicative of the singly esterified AI and AII respectively, and the peaks at m/z 1324 and
m/z 1074 correspond to the doubly (fully) esterified AI and AII, respectively. The high
peak intensities of doubly methylated AI and AII indicate high conversion rates of the
derivatization for both model peptides.
In addition to the model peptides, evaluation of the in-vial methyl esterification
effectiveness was further extended to peptide mixtures obtained from the tryptic digest of
the phosphoprotein β-casein. β-Casein is chosen as a source of two phosphorylated
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peptides after proteolytic digestion: one monophosphorylated peptide at m/z 2061.82, and
one tetraphosphorylated peptide at m/z 2966.16, usually found with one missed cleavage
(m/z 3122.26 with a leading arginine at N-terminal). A list of peptides from β-casein
tryptic digest are listed as follows in Table 3.3, with the calculation of [M + H]+ for the
original peptides and the anticipated fully methyl esterified counterparts.
Table 3.3 Peptides commonly identified from the tryptically digested β-casein, in the
increased order of molecular mass. Amino acid residues that are possible esterification
sites are labeled in blue color with “m” representing the addition of methyl groups via the
derivatization.
Peptide Sequence

[M + H]+ Expected Fully Methyl Esterified Products

Calculated
[M + H]+

EAMAPK

646.32 mEAMAPKm

674.35

VLPVPQK

780.49 VLPVPQKm

794.51

GPFPIIV

742.45 GPFPIIVm

756.47

EMPFPK

748.37 mEMPFPKm

776.40

AVPYPQR

830.45 AVPYPQRm

844.47

YPVEPFTER

1137.55 YPVmEPFTmERm

1179.60

LLYQEPVLGPVR

1383.65 LLYQmEPVLGPVRm

1411.68

HQGLPQEVLNENLLR

1759.94 HQGLPQmEVLNmENLLRm

1801.99

FQSEEQQQTEDELQDK

1981.56 FQSmEmEQQQTmEmDmELQmDKm

2079.67

FQ(pS)EEQQQTEDELQDK

2061.82 FQ(pS)mEmEQQQTmEmDmELQmDKm

2159.93

DMPIQAFLLYQEPVLGPVR

2186.16 mDMPIQAFLLYQmEPVLGPVRm

2228.21

RELEELNVPGEIVE(pS)L(pS)
RmELmEmELNVPGmEIVmE(pS)L(pS)(pS
3122.26
(pS)(pS)EESITR
)(pS)mEmESITRm

3234.39

In the circumstance of real application in phophopeptide detection after methyl
esterification, the resulting decrease in heterogeneity will maximize phosphopeptide
signal intensity in MS. Furthermore, gaining better understanding of these minor but
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unavoidable side products which can be generated by the esterification chemistry will aid
peak assignment and database searching of MALDI MS data. The tryptically digested βcasein was therefore selected as a standard peptide mixture to evaluate the potential for
the methyl esterification on phosphorylated peptides as well as the derivatization
effectiveness on a variety of peptides. Figure 3.4 displays a series of magnified MALDI
mass spectra to show the individual in-vial methyl esterfication result for six peptides
respectively.
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Figure 3.4 MALDI mass spectra showing the enlarged profiles of selected six peptides
from 0.02 mg/mL β-casein tryptic digest after in-vial methyl esterification: (A) GPFPIIV
(m/z 742.45); (B) AVPYPQR (m/z 830.45); (C) YPVEPFTER (m/z 1137.55); (D)
LLYQEPVLGPVR (m/z 1383.65); (E) FQ(pS)EEQQQTEDELQDK (m/z 2061.82); (F)
DMPIQAFLLYQEPVLGPVR (m/z 2186.16). Esterification sites are labeled in blue
color in the peptide sequences with “m” representing the addition of methyl groups, and
deamidation sites are labeled in red color.
Peptide GPFPIIV ([M + H]+ m/z 742.45) displays no signal of underivatized peak
but a predominant signal at m/z 756.47, suggesting an effective conversion to the
corresponding methyl ester on the C-term (Figure 3.4 A).

Likewise, peptide

YPVEPFTER ([M + H]+ m/z 1137.55) also exhibits a high conversion rate with only
small amount of doubly esterified products and considerably high intensity of triply (fully)
esterified peak (Figure 3.4 C).
It is also seen in these mass spectra that certain peptide species gave rise to peaks
with a mass shift of 15 Da from the fully derivatized products. Since the formation of
methyl esters results in and increase of 14.03 Da in mass for each carboxylate group
present, the most possible explanation for this unusual mass increment was deamidation
of the asparagine residue, which, by conversion to an aspartate residue, would increase
the mass by 0.985 Da (-NH2 to -OH). It has been suggested that under the harsh
condition used for esterification the expected deamidation reaction may take place,
yielding the plus-15 Da products.10, 15 Overall speaking, during the reaction process,
esterification and deamidation can occur on acidic or amide-containing amino acid
residues, and the C-terminal amide group, leading to mass shift of 14 or 15 Da for each
conversion.3, 15 Amino acid residues containing carboxamide groups (N/Q) are located in
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several peptide fragments in the β-casein tryptic digest. As illustrated by Figure 3.4 B,
for peptide AVPYPQR ([M + H]+ m/z 830.46), esterification went to completion for all
the carboxylate moieties and that negligible traces of the underivatized peptides are
present in the mass spectrum. In the presence of one Q residue, another mass shift of 15
Da was expected. Similarly, peptide LLYQEPVLGPVR with [M + H]+ at m/z 1383.65,
presents an almost complete conversion to its fully esterified counterpart with no
presence of underivatized signal (Figure 3.4 D). A characteristic mass shift of 15 Da
along with abnormal isotopic distribution was observed, an indicator of the deamidationmethyl esterification reaction occurring at the amide group of the Q residue present in the
sequence.

With three possible esterification sites in the peptide sequence

DMPIQAFLLYQEPVLGPVR, which gives the monoisotopic peak ([M + H]+) at m/z
2186.16, the corresponding triply esterified product at m/z 2228.19 was observed,
together with the detection of a doubly esterified peak of minor intensity at m/z 2214.20
(Figure 3.4 F). Sodium adducts of small intensities were detected as well. Nonetheless,
high-intensity peaks of the deamidation products were observed with two consecutive
mass shifts of 15 Da at m/z 2243 and 2258 in the presence of two Q residues in the
sequence.
Another issue that enhances complexity of MALDI mass spectra is the formation
of metal ion adducts. During UV excitation, several reactions are known to occur in the
MALDI source: formation of radical cations via electron-transfer, generation of singly
charged ions via protonation, and production of cationized molecules in the form of metal
ion adducts.16 The observation of metal ion adducts, mostly with alkali metal ions such
as sodium and potassium, became more pronounced for low-intensity species. This is
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specially the case for the monophosphorylated species FQ(pS)EEQQQTEDELQDK ([M
+ H]+ m/z 2061.82) that we are most interested in, yielding a fully methyl esterified peak
at m/z 2159.96 with all seven of its esterification sites being converted to methyl esters
(Figure 3.4 E).

However, the presence of five Q residues also contributed to the

complication of the mass spectrum, giving rise to deamidation products at m/z 2175.00
and m/z 2189.95 or even at m/z 2197.25 as a combination of both side reaction and
sodium adduct [M + Na]+. Furthermore, the predominant signal at m/z 2182.25 was
deduced to be merely a sodium adduct of the fully derivatized peak with a mass shift of
22 Da. The overwhelmed signal of our target peptide by its sodium adduct can be
detrimental to mass spectrometric quality and in the long term, the effectiveness of
peptide mapping after methyl esterification.

3.3.1.2

In-Capillary Reaction

After the investigation of the in-vial methyl esterification effectiveness, the next
step is to explore the application of the in-vial chemistry in a miniaturized manner using
CE instrumentation. An advantage to performing the esterification inside a capillary is
that the removal of organic solvents prior to MS analysis can be exempted. This is
because the spot volume with the in-capillary method (35 nL) was much smaller
compared with the in-vial approach (0.25 µL). In contrast, it is impossible to obtain MS
data when the reaction mixture is simply pipetted onto the pre-spotted matrix. Another
advantage of using the capillary as a miniaturized reaction vessel is the lowered detection
limit and thereby enhanced detection sensitivity in comparison to traditional MALDI-MS
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spotting method, possibly attributed by the sub-microliter amount of sample spotted and
minimization of sample loss.
In-capillary incubated methyl esterification was proposed in a previous master
thesis in which the reactants were mixed in a vial prior to injection into a capillary such
that the capillary was essentially treated as a reaction vessel only.9 It was reproduced in
this work and comparable results were obtained in terms of the esterification
completeness (data not shown). However, to further lower down the sample consumption
and take full advantage of CE instrumentation, an attempt for in-capillary mixed reaction
was also explored. Initial study on in-capillary mixing has been presented in a former
master student’s work, in which mixing by pressure application and by voltage
application were respectively attempted.9 Transverse diffusion of laminar flow profiles
(TDLFP) is considered as a generic approach for mixing reactants inside a capillary
microreactor and in-capillary mixing of the reagents by diffusion was attempted.7 Simply,
the experimental design of in-capillary mixing and incubation was performed by
hydrodynamic injection of alternating bands of peptides and MeOH-HCl. In the course
of successive injections, alternating sample zones and reagent zones can be ideally mixed
by transverse diffusion so that they react with each other, as depicted in Figure 3.5.
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Injection

2 M MeOH-HCl

Mixed by Diffusion

Outlet

Anhydrous
MeOH

Anhydrous
MeOH

Inlet

In-capillary Incubation
Peptides in
Anhydrous MeOH

Figure 3.x : Schematic of in-capillary methyl esterification with injections of

Figure 3.5 alternating
Schematic
of in-capillary methyl esterification. Injections of reactants were
bands of methanolic-HCl and peptides dissolved in anhydrous methanol,
are subsequently
mixed
diffusion and subject
to in-capillary
incubation.
performed which
as alternating
bands
of byMeOH-HCl
and peptides
dissolved
in anhydrous
methanol, subsequently mixed by diffusion and subject to in-capillary incubation.
The resulting products were subject to off-line MALDI MS analysis via the
application of constant pressure (50 mbar) at the capillary inlet for 20 s, yielding a 35 nL
volume fraction per sample spot. Figure 3.6 illustrates the resulting MALDI mass
spectrum from the in-capillary methyl esterification after 1 h of reaction time on model
peptides AI & AII. The absence of native peptide(s) indicates a complete reaction.
Predominant signals of fully methyl esterified peptides were detected along with minor
sodium adducts. The mass spectra corresponding to methyl esterified products obtained
via both methods revealed the molecular peak of doubly esterified AI [M + H]+ at 1324
Da and AII [M + H]+ at 1074 Da as well as their corresponding sodium adducts [M +
Na]+ at 1346 Da and 1096 Da respectively. There appears to be less formation of singly
esterified peptide formed when an in-capillary approach was used. It is entirely possible
that in contrast to the in-vial reaction, performing the reaction in-capillary generally had
less exposure to the atmosphere (which might contain water vapor) since two ends of the
capillary were immersed in anhydrous methanol for the duration of the reaction. In sum,
comparable or even better results were obtained for the in-capillary method compared to
the in-vial method, in consideration of the degree of completeness for methyl
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esterification.

However, this requires other more quantitative methods for further

confirmation.
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Figure 3.6 mass spectrum obtained after 1 h of in-capillary methyl esterification.
Peptides AI and AII were at a concentration of 2 μg/mL. Esterification sites are labeled
in blue color in the peptide sequences with “m” representing the addition of methyl
groups.

3.3.1.3

On-Capillary-Tip Hanging Droplet Reaction

The idea of performing an on-capillary-tip methyl esterification was derived from
the complete mixing of reactants in a miniaturized manner. The MALDI mass spectrum
resulting from the on-capillary-tip hanging droplet method is shown in Figure 3.7. Only
very low esterification ratio was reached due to the observation of predominant peaks of
underivatized AI and AII at m/z 1296 and m/z 1046, with second predominant peaks of
singly methyl esterified AI and AII at m/z 1310 and m/z 1060 and very low intensities of
the fully derivatized products. This approach appears to be a lot less effective with
respect to the formation of fully esterified products, in comparison to either the in-vial or
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the in-capillary trial. A reasonable explanation is that the airtightness was still poor
although the droplet was kept in a capped vial for the duration of the reaction. As has
been stated before, if water is present in the reaction, acid chloride can react with it to
reform a carboxyl group. Thereby, with exposure to the moisture in the atmosphere, the
completeness of the esterification was tremendously impaired. Another plausible reason
is the evaporation of the esterifying agents, especially the volatile hydrochloride in
MeOH-HCl.

Although measures were taken to prevent solvent evaporation of the

hanging droplet such as keeping an enough amount of methanol in the sealed vial to form
saturated vapor, there seemed to be less effective esterifying ability for this set-up. As a
consequence, new methods have to be developed for effective esterification at the
capillary tip.
Unesterified AII
DRVYIHPF
m/z 1046.34

Singly methyl esterified AII
mDRVYIHPF
or DRVYIHPFm
m/z 1060.36

3

2.0
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Unesterified AI
DRVYIHPFH
Singly methyl esterified AI
m/z 1296.42
mDRVYIHPFH
or DRVYIHPFHm
m/z 1310.44

1.5

Doubly methyl esterified AII
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m/z 1074.38

1.0

Doubly methyl esterified AI
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Figure 3.7 MALDI mass spectrum obtained after 1 h of on-capillary-tip hanging droplet
methyl esterification. Peptides AI and AII were at a concentration of 0.02 mg/mL.
Esterification sites are labeled in blue color in the peptide sequences with “m”
representing the addition of methyl groups.
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3.3.2

Completeness of Methyl Esterification with Variant Reaction
Times
For methyl esterification some procedures reported conversion to fully esterified

product in less than 1 h with side product and sample degradation occurring with longer
reaction times.17 Others reported longer reactions sometimes followed by evaporation of
the reaction mixture and repeating the reaction.4, 5 It is of importance to investigate the
efficiency of the derivatization procedure by studying the reaction proceeding as a
function of reaction time.

3.3.2.1

In-Vial Reaction Time

In this work, esterification efficiency for both model peptides and peptide
mixtures from β-casein tryptic digest was investigated in both in-vial and in-capillary
approaches, respectively. The in-vial reaction was performed using model peptides AI
and AII with variant reaction time: 20 min, 40 min, 60 min and 2 h. With a fast reaction
rate, after 20 min there was no starting material for both AI and AII, and peak
representing the full esterification products appeared (MALDI mass spectra not shown).
It seems that after 1 h the reaction has gone to completion and increased reaction times up
to 2 h did not result in an enhancement of the fully esterified peptide signals. This short
period of time for the esterification to proceed may be attributed to either the small sizes
of the model peptides (8 to 9 amino acid residues) or the limited sites for esterification.
It has been proposed in previous studies that peptides with only a few sites for
esterification take less time to fully esterify while peptides which are larger and have
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more possible sites for esterification take more time and potentially several rounds of
esterification.9

Figure 3.8 shows the in-vial methyl esterification result for the

monophosphopeptide ([M + H]+ m/z 2061) from β-casein tryptic digest after 1 h of
reaction time. Interestingly, even in the presence of seven carboxylic groups as possible
esterification sites in its sequence FQ(pS)EEQQQTEDELQDK (labeled in blue color),
the reaction goes to completion with majorly septuply esterified products ([M + H]+ m/z
2160) a limited presence of the sextuply esterified peak ([M + H]+ m/z 2146) within a
short period of reaction time (1 h). Therefore, the esterification efficiency might not be
simply related to either peptide size or number of esterification sites, or even being an
integrated outcome of several factors including hydrophobicity and isoelectric point (pI).
Septuply (Fully) methyl esterified
FQ(pS)mEmEQQQTmEmDmEL
QmDKm
m/z 2159.98

400

Intensity (Ion Counts)

300

Sextuply methyl esterified
m/z 2145.98

200

100

0
2140

Figure

3.8

2145

Enlarged

2150

MALDI

2155
m/z

mass

spectrum

2160

2165

of

the

2170

monophosphopeptide

FQ(pS)EEQQQTEDELQDK (m/z 2061.82) after 1 h of in-vial methyl esterification.
Peptides obtained from β-casein tryptic digest were at a concentration of 0.04 mg/mL.
Esterification sites are labeled in blue color in the peptide sequences with “m”
representing the addition of methyl groups.
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3.3.2.2

In-Capillary Reaction Time

The reaction efficiency was also gauged for the in-capillary approach, and for
model peptides AI and AII, the in-capillary method appears to follow the same trend as
the in-vial method (data not shown). A preliminary conjecture can be derived from this
relatively high reaction rate, that the difference in reaction times is likely contributed by
the number of carboxyl groups in the starting material. To take one step further, the incapillary approach was also tested on a peptide mixture obtained from β-casein tryptic
digest, which provides a relatively wide range of peptides including a phosphopeptide in
which our special interest lies.
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Figure 3.9 Enlarged profiles of MALDI mass spectra of six in-capillary methyl esterified
peptides from β-casein tryptic digest: (A) GPFPIIV (m/z 742.45); (B) AVPYPQR (m/z
830.45); (C) YPVEPFTER (m/z 1137.55); (D) LLYQEPVLGPVR (m/z 1383.65); (E)
FQ(pS)EEQQQTEDELQDK (m/z 2061.82); (F) DMPIQAFLLYQEPVLGPVR (m/z
2186.16). Sample concentration was 0.04 mg/mL. Esterification results with variant
reaction time of 20 min, 40 min and 60 min were examined. Esterification sites are
labeled in blue color in the peptide sequences with “m” representing the addition of
methyl groups, and deamidation sites are labeled in red color.
As is shown in the above series of mass spectra for six selected peptides from βcasein tryptic digest, in-capillary methyl esterification was successfully conducted to
acquire mostly fully esterified products for the major peptides along with some side
products and salt adducts during MALDI ionization. Compared to the in-vial method,
there seems to be less formation of side products resulting from deamidation on amidecontaining amino acid side chain. However, even increasing the concentration to 0.04
mg/mL, there were a few peptides that could not be detected using the in-capillary
method, possibly due to low abundances and poor ionization efficiency caused by
ionization suppression from abundant peptides. Peptide GPFPIIV ([M + H]+ m/z 742.5)

2250
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showed no signal of underivatized peak only after 1 h of reaction time (Figure 3.9 A).
As illustrated by Figure 3.9 B, for peptide AVPYPQR ([M + H]+ m/z 830.5),
esterification went to completion for all the carboxylate moieties and that negligible
traces of the underivatized peptides were present after 1 h, with a mass shift of 15 Da as
the deamidation product on the Q residue. Peptide YPVEPFTER ([M + H]+ m/z 1137.6)
also displayed a high conversion rate with only small amount of doubly esterified
products and considerably high signal of fully esterified peak after 1 h of reaction time
(Figure 3.10 C). However, peptide LLYQEPVLGPVR ([M + H]+ m/z 1383.6) presents
an incomplete conversion to its fully esterified products and significant signal of the
doubly esterified products with a mass shift of 15 Da as an indication of the deamidationmethyl esterification reaction occurring at the amide group of the Q residue (Figure 3.9
D). Peptide DMPIQAFLLYQEPVLGPVR ([M + H]+ m/z 2186.2), the corresponding
fully esterified product at m/z 2228.2 was observed, together with the detection of a
doubly esterified peak of minor intensity at m/z 2214.2 (Figure 3.9 F). However, the
underivatized signal and the sodium adducts were detected as well, and high-intensity
peaks of the deamidation products were observed at m/z 2243.2. The fully methyl
esterified monophosphopeptide, however, was only detected as its sodium adducts at m/z
2181.9 (Figure 3.9 E).
A list of our studied peptides from β-casein tryptic digest is shown as follows in
Table 3.4, with the calculation their pIs, number of esterification sites and number of
amino acid residues. It has been a preliminary assumption that esterification rate is
attributed to peptide size, peptide abundance, pI, hydrophobicity or other possible factors
such as differences of MALDI MS ionization efficiencies.

The in-capillary timed
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reaction, however, illustrated scattered results for the derivatized peptide fragments,
indicating that the esterification efficiency is probably a peptide-dependent outcome. For
some peptides higher conversion rate can be obtained in a short amount of time, but for
other peptides, longer reaction time or repeated esterification only give rise to more side
deamidation or oxidation products.

The optimization of the overall esterification

efficiencies for a peptide mixture is to some degree governed by the peptides’ properties.
Table 3.4 A list of peptides commonly identified from the tryptically digested β-casein,
in the increased order of calculated pI.
Peptide Sequence

[M + H]+

RELEELNVPGEIVE(pS)L(pS)
3122.26
(pS)(pS)EESITR

Calculated
Number of
Number of
pI
Esterification Sites A.A Residues
1.37

8

25

FQ(pS)EEQQQTEDELQDK

2061.82

3.29

7

16

FQSEEQQQTEDELQDK

1981.56

3.77

7

16

DMPIQAFLLYQEPVLGPVR 2186.16

4.37

3

19

YPVEPFTER

1137.55

4.48

3

9

GPFPIIV

742.45

5.52

1

7

HQGLPQEVLNENLLR

1759.94

5.62

3

15

LLYQEPVLGPVR

1383.65

6.00

2

12

EAMAPK

646.32

6.10

2

6

EMPFPK

748.37

6.10

2

6

VLPVPQK

780.49

8.72

1

7

AVPYPQR

830.45

8.79

1

7
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3.3.3

Effect of Methyl Esterification on MALDI Ion Detection Mode
Previously we have demonstrated the results of performing in-capillary methyl

esterification on phosphopeptides, mass spectra recorded in negative ion mode show
lower abundances of multiply charged species, lower background, higher reproducibility,
and, thus, overall cleaner spectra compared with positive ion mode spectra.18 It has been
has demonstrated in a preceding study that the conversion of carboxylic groups to their
corresponding esters is contributive to the improved detection of the modified
counterparts.19 The negative ion mode for MALDI MS identification of phosphopeptide
showed advantageous over the positive ion mode after derivatization of the carboxylate
groups by methyl esterification.

Additionally, methyl esterification displayed the

tendency to increase MALDI detection of the modified protonated peptide ions. In
negative mode, esterification tends to exert a deleterious effect on the ion yield of the
corresponding deprotonated species.
To elucidate whether modifications of the acidic character of peptides prevent
formation of anionic species under MALDI analysis, comparison can be made between
the mass spectra obtained from both positive and negative modes. Comparing the mass
spectra derived from the methyl esterified products of β-casein tryptic digest, there are
less observable peaks in the MALDI negative ion mode (data not shown). Although
phosphorylated peptides of β-casein produced peptide signals with higher relative
abundance, the protein sequence coverage was lower in negative ion mode compared to
that of the positive ion mode. This is explainable since non-phosphorylated peptides
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contain a positively charged lysine or arginine at the C-terminus as well as a positively
charged amino terminus.
However, there is no evidence that in the negative (or positive) mode, methyl
esterification can contribute to signal enhancement of the phosphorylated species. This is
not matched up with previously published work which demonstrated that with peptide
esterification on the proteolytic digest of phosphoproteins, negative ion detection in
MALDI can provide a distinct advantage over the positive ion mode of operation for
phosphopeptide analysis, even without IMAC enrichment.10

3.3.4

On-Capillary-Tip Sample Recovery
The next step is to explore a method to recapture target peptide inside the

capillary, and hopefully to preconcentrate the broad plug into a narrow band for
enrichment purpose. In our lab, a discontinuous buffer system has been developed to
perform partial IEF separation of peptides resulting from in-capillary tryptic digestion
prior to MALDI-MS analysis.

In addition to the dynamic pH junction for sample

stacking, solid phase extraction is also an exciting method especially the usage of
superparamagnetic particles. In a microanalytical method reported by Rashkovetsky et
al., magnetic beads (MBs) were used in combination with CE instrumentation.20 A short
plug of MBs can be localized into the capillary and held fixed by an external magnet.
Ideally, by adopting capillary-located MBs, target peptides could be captured at specific
conditions and eventually contribute to an in-capillary trapping.

Nevertheless, the

presence of esterifying reagent used can be extremely problematic to these two
prospective approaches. Therefore, a better method has to be developed in order to
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increase the compatibility of this in-capillary methyl esterification system to the aqueous
environment for subsequent sample enrichment.
For the in-vial experiment, in order to dry down the esterified products to
complete dryness, either SpeedVac or lyophilization approach can be adopted, while for
the in-capillary reactions (incubated/mixed), the situation becomes more complicated.
Considering the anhydrous environment required for a high conversion rate of the
esterification, drying the capillary contents has to be performed with much care.
Moreover, the re-introduction of the sample inside the capillary as a narrow band for
subsequent analysis remains also another issue of importance. A new design is therefore
proposed here to remove the unwanted organic solvents (MeOH-HCl) from the system.
In this approach, after the reaction reaches completion, high pressure (1 bar) is applied to
flush the entire capillary contents into a hanging droplet, which can be directly dried at
the capillary tip by a flow of N2 gas. After complete removal of any remanent solvent, a
droplet of buffer (1 µL) was directly pipetted onto the capillary tip and sat for 30 s, and
the peptide recovery were evaluated in MALDI MS using recovery buffers (Figure 3.10).
In consideration of the compatibility with MBs-based sample enrichment as well as the
feasibility of establishing a dynamic pH-junction for preconcentration, four different
composition was chosen for the recovery buffers/solutions: 50% acetonitrile (ACN), 1%
TFA, 10 mM pH 9 ammonium acetate (AmAc), 50% ACN in 10 mM pH 9 AmAc. The
results were listed in Table 3.5 (MALDI MS raw data not shown).
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Pressure

Sample Droplet: 1 μL
Recovery Buffer: 1 μL
N2 Flow

Figure 3.10 Schematic of on-capillary-tip droplet sample recovery test.
Table 3.5 Peptides identified from the tryptically digested β-casein recovered from the
on-capillary-tip using four types of recovery solutions.
Recovery Buffer (Solution)
Peptide Sequence

[M + H]+ Control

AVPYPQR

830.45

✓

VLPVPQK

780.5

✓

EAMAPK

646.32

✓

EMPFPK

748.37

✓

LLYQEPVLGPVR

1383.65

✓

HQGLPQEVLNENLLR

1759.94

✓

GPFPIIV

742.45

✓

YPVEPFTER

1137.55

DMPIQAFLLYQEPVLGPVR

2186.16

FQSEEQQQTEDELQDK

1981.56

FQ(pS)EEQQQTEDELQDK

2061.82

50%
1% TFA
ACN
✓

✓

10 mM
50% ACN in 10
pH 9
mM pH 9 AmAc
AmAc
✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

RELEELNVPGEIVEpSLpSpS
3122.26
pSEESITR

Attempts to detect the tetraphosphorylated peptide peak ([M + H]+ m/z 3122)
without any preconcentration and enrichment were not successful in all of the samples, in
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large part due to ion suppression from other abundant peptides, as well as poor ionization
efficiency resulting from both large size (>3000 Da) and the presence of multiply
phosphorylated sites.

The monophosphorylated peptide ([M + H]+ m/z 1961) was

observed in all samples with variant intensities. Overall speaking, most of the peptides
from β-casein tryptic digest can be recovered using the four selected recovery buffer
regardless of the presence of organic phase (ACN) or specific salts (AmAc) or acidity
(TFA), which might result from the low retention of the fused silica surface after
removing the polyimide coating. This is desirable because the possibility of choosing
various recovery buffer solutions can contribute to the flexibility of this system for the
hyphenation to other procedures. As is shown by Figure 3.11, up to 60~90% MS
intensity recovery was obtained within the mixture of peptides from β-casein tryptic
digest by using 10 mM pH 9 AmAc as the recovery buffer, indicating the feasibility of an
on-line coupling with this system to an in-capillary enrichment or that the capturing
ability of MBs can be tested in this recovery buffer for a range of peptides. Although
MALDI-MS is not a qualitative technique as the degree of sample ionization account for
the observed signal intensity, which can be affected by a number of factors such as
crystallization, sample dryness, degree of acidity, and the MS instrumental parameters,
the recovery ratio still provides some insight into the feasibility of integrating our incapillary methyl esterification and on-capillary tip solvent removal steps with sample
recapture and enrichment. With this desirable recovery of peptides using aqueous buffers,
the proposed scheme of on-capillary-tip sample recovery followed by recapturing the
recovered sample inside the capillary can be tested in the near future.
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Figure 3.11 MALDI MS results of on-capillary-tip droplet sample recovery test on βcasein tryptic digest with the magnified window showing the MS signal of the
monophosphopeptide FQ(pS)EEQQQTEDELQDK (m/z 2061.82): (A) control; (B)
recovered sample. Peptides obtained from β-casein tryptic digest were at a concentration
of 0.04 mg/mL. 10 mM pH 9 AmAc was used as the recovery buffer.

3.4

Conclusions
Both in-vial and in-capillary methyl esterification were performed in a

comparison of reaction effectiveness and efficiency. Undoubtedly, advantages of the incapillary method over the in-vial method were evidenced by the largely reduced sample
consumption and higher detection sensitivity.

In this work, an in-capillary methyl

esterification method was developed as a miniaturized derivatization scheme for the
detection of phosphopeptides. Nevertheless, in order to use esterification as an effective
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analytical methodology of phosphopeptide followed by MS analysis, there are still
prerequisites side reactions such as oxidation should be avoided or minimized to reduce
spectral complexity.

With regards to the enhanced identification of phosphorylated

peptides, enrichment step is also included. By taking advantage of the in-capillary
reaction combined with preconcentration by a dynamic pH junction or peptide recapture
enable by magnetic beads (MBs), an integrated procedure can hopefully be developed.
However, to come up with this, the compatibility of the methyl esterification system to
the aqueous environment usually used in pH junction or sample enrichment by MBs has
to be addressed. An easy way of solvent removal particularly for methyl esterification
was investigated in this work by conducting on-capillary-tip sample recovery test. The
results indicated that the next step of sample enrichment can be integrated into the system.
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Chapter 4.

Conclusions and Future work
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4.1

Conclusions
Chapter 1 presented efforts towards instrumental analysis of ADP-ribosylation by

CE, with an essential focus on ARTD-10 cat. The hypothesis of an unsuccessful in vitro
mono-ADP-ribosylation attempt was preliminary raised on the basis of CE experimental
results. The MALDI-MS data was also a good supplement to our evidence, denoting no
sign of ADP-ribosylation modification on the sample. Subsequently, the interactions
between DTT and ARTD-10 cat, potentially disulfide bridge(s) by reduction, were
revealed by peak shifts observed in CE analysis. This finding was underpinned by the
same pattern of band shifts in reducing as well as non-reducing GE by using another
reducing agent BME.

Collectively, these data indicate that the attempts for ADP-

ribosylating ARTD-10 were not successful. We also confirmed that DTT was accounted
for both Tm differences in CE and band shifts in GE, which were resulted from reduction
of the disulfide bridge(s) in ARTD-10 cat. However, there existed some observations
that could not been explained so far, such as the double peak of ARTD-10 cat presented
at pH higher than 5 and the observed 200 Da smaller MW in MS compared to the
theoretical MW. This work has brought some light on the analysis of ARTD-10, yet a
substantial amount of work is going to be done to fully resolve the PARP biochemistry.
In addition to high-efficiency separation, sample preparation accounts for an
important branch in CE applications.

Due to MS ionization suppression,

phosphopeptides have to be enriched or derivatized in order to obtain reasonably goodquality signals. Methyl esterification is usually performed to block the acidic amino acid
side chains in the phosphorylated species to reduce non-specific sample binding in IMAC.
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In this work, both in-vial and in-capillary methyl esterification were performed and
reaction effectiveness and efficiency were evaluated. Undoubtedly, advantages of the incapillary method over the in-vial method were evidenced by the largely reduced sample
consumption and higher detection sensitivity. In order to use esterification as an effective
analytical methodology of phosphopeptide followed by MS analysis, there are still
prerequisites side reactions such as oxidation should be avoided or minimized to reduce
spectral complexity.

With regards to the enhanced identification of phosphorylated

peptides, enrichment step is also included. By taking advantage of the in-capillary
reaction combined with preconcentration by a dynamic pH junction or peptide recapture
enable by magnetic beads (MBs), an integrated procedure can hopefully be developed.
However, to come up with this, the compatibility of the methyl esterification system to
the aqueous environment usually used in pH junction or sample enrichment by MBs has
to be addressed. An easy way of solvent removal has also been investigated in this work
by conducting on-capillary-tip sample recovery test. The results indicate that the next
step of sample enrichment can be integrated into the system.

4.2

Future Work
To identify and characterize the inter- or intra-molecular disulfide bridges in the

intact protein structures, digestions have to be performed under non-reducing conditions,
followed by MS or MS/MS analysis.

Major tasks include the identification of the

number of disulfide bonds, the localization of the inter- or intra-molecular disulfide
linkages, and also hopefully the characterization of the 3D structures of ARTD-10 cat.
On the other hand, the ease of integrating sample pretreatment directly in-capillary
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represents a unique feature of CE for realizing high-throughput and low-cost analyses,
where the capillary can serve as preconcentrator, desalter, microreactor, chiral selector
and simulator.1 Among the diverse functionalities, online techniques such as in-capillary
derivatization or sample stacking have both been reported as effective methodologies for
enhancing the detection sensitivity. The combination of these two techniques can result
in a more powerful alternative which does not require extra equipment.2 To develop an
online-preconcentration system in CE using dynamic pH junction, or immobilized MBs
to fufill in-capillary sample enrichment task, are the two basic directions for the future
work in the CE sample preparation for the analysis of protein/peptide phosphorylation.
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Appendices
Appendix A: General remarks on linear mode and reflectron mode for the TOF mass
analyzer
TOF mass analyzers separate accelerated ions based on the differences between their
velocities. The operating principles of TOF mass analyzers are elegantly simple. For this
method, an ion is given a fixed amount of kinetic energy by acceleration in an electric
field that is generated by the application of a high voltage. Following acceleration, the
ion enters a field-free region where it travels at a velocity that is inversely proportional to
its m/z. Because of this inverse relationship, ions with low m/z travel more rapidly than
ions with high m/z.

In a TOF mass analyzer, a "pulse" (or "bundle") of ions is

accelerated out of the source by a reasonably high voltage in a vacuum tube, and the ions
are then allowed to drift in the field-free region to the detector. The ions all have
identical kinetic energies and thus the heavier ions travel slower than the lighter ions.
Thus the separation of the ions is dependent on their respective “flight time”, namely the
length of time for each ion to travel along the flight tube before reaching the detector.
This is achieved by the ions with smaller masses arriving at the detector faster than ions
with larger masses i.e. ions with smaller mass will have a shorter "flight time". A time
signal is initiated when the ions are pulsed out of the ion source and also when they arrive
at the detector, so that the time of flight can be measured, which is proportional to the
square root of its m/z value. The larger the mass of a singly charged ion, the longer it
takes to travel through the field-free region. Essentially, TOF mass analyzer has an
unlimited mass range, and hence can be ideally applicable to analyzing polymeric
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materials as well as large biological molecules. TOF mass spectrometers can be typically
classified into two broad categories, linear and reflector-type instruments.

In the linear mode, MALDI-TOF analyzer works in such a simple way that the
time of flight is measured as the time it takes for a specific ion to fly from one end to the
detector.

The linear mode often suffers from poor resolution for continuous ion

extraction, due to the relatively broad distribution of initial velocities. That is, when
analytes with the same m/z ratio are ionized their kinetic energies are not necessarily
identical. If the acceleration potential would be continuously turned on, such that the
ions are accelerated instantaneously upon being formed, the ions with the same m/z value
but with different momentum reach the detector at slightly different times, resulting in
peak broadening. To resolve this, delayed ion extraction is usually employed in linear
TOF to enhance mass accuracy over a broad mass range by focusing velocity distribution
with the optimal time lag. Delayed extraction refers to a delay in the onset of the
acceleration potential by a short time after the ionization has occurred. The delay time
acts as a focusing element, which will lead to simultaneously detection of the ions, due to
acceleration in the ionization chamber. Delayed extraction is often used in MALDI ion
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sources, due to the focusing effect. In view of the resolution issue, linear TOF is usually
used for the analysis of proteins or large peptides.

In order to improve the resolving power of TOF instrument, reflectron, an ion optic,
mirror-like device in the ion acceleration region can be used to reflect ions of the same
m/z values that have different energies. Ions with greater kinetic energies penetrate
further into the reflection than those with smaller kinetic energies.

The ions that

penetrate further also spend a longer time in the reflectron, and thus take longer to reach
the detector. The overall effect is that the reflectron decreases the spread in the flight
times for ions of the same m/z ratio but different kinetic energies, and therefore
resolution and mass accuracy are both improved.

TOF instruments using delayed

extraction and reflectron ion optics with high data acquisition speeds to give an m/z
resolution greater than 10,000, will provide mass accuracies in the 5- to 20-ppm range.
As a whole, reflectron TOF instruments typically present much higher resolution and
mass accuracy than their linear counterparts: reasonable resolution of the isotopes is
obtained in the case of reflectron TOF analysis, compared with a single averaged peak in
the case of the linear mode.
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Appendix B: Calculated total net charges for the unmodified form and modified (monoADP-ribosylated) form of ARTD-10 cat under different pH conditions.
Unmodified

pyrophosphate group

Modified

pH

Charge

pKa1=0.91

pKa2=2.10

Charge

0

41

-0.1095494

-0.00788

40.88257

0.25

41

-0.1795048

-0.01393

40.80657

0.5

41

-0.280081

-0.0245

40.69542

0.75

41

-0.4089244

-0.04276

40.54832

1

41

-0.5516235

-0.07359

40.37479

1.25

41

-0.6863003

-0.12377

40.18993

1.5

40.9

-0.7955199

-0.20076

39.90372

1.75

40.9

-0.8737104

-0.30876

39.71753

2

40.8

-0.9248272

-0.44269

39.43248

2.25

40.7

-0.9562892

-0.5855

39.15821

2.5

40.5

-0.9749402

-0.71525

38.80981

2.75

40.2

-0.9857516

-0.81708

38.39717
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3

39.7

-0.9919372

-0.88818

37.81988

3.25

39

-0.9954499

-0.93389

37.07066

3.5

37.9

-0.9974362

-0.96171

35.94085

3.75

36.3

-0.9985566

-0.9781

34.32334

4

34.1

-0.9991878

-0.98757

32.11324

4.25

31.3

-0.9995431

-0.99297

29.30749

4.5

28.2

-0.999743

-0.99603

26.20422

4.75

25.3

-0.9998555

-0.99777

23.30238

5

22.8

-0.9999187

-0.99874

20.80134

5.25

20.9

-0.9999543

-0.99929

18.90075

5.5

19.3

-0.9999743

-0.9996

17.30042

5.75

17.8

-0.9999855

-0.99978

15.80024

6

16.1

-0.9999919

-0.99987

14.10013

6.25

14.2

-0.9999954

-0.99993

12.20008

6.5

12.1

-0.9999974

-0.99996

10.10004

6.75

10

-0.9999986

-0.99998

8.000024

7

8.1

-0.9999992

-0.99999

6.100013

7.25

6.6

-0.9999995

-0.99999

4.600008

7.5

5.5

-0.9999997

-1

3.500004

7.75

4.4

-0.9999999

-1

2.400002

8

3.4

-0.9999999

-1

1.400001

8.25

2.2

-1

-1

0.200001

8.5

1

-1

-1

-1

8.75

-0.3

-1

-1

-2.3
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9

-1.6

-1

-1

-3.6

9.25

-3

-1

-1

-5

9.5

-4.6

-1

-1

-6.6

9.75

-6.5

-1

-1

-8.5

10

-8.5

-1

-1

-10.5

10.25

-10.6

-1

-1

-12.6

10.5

-12.5

-1

-1

-14.5

10.75

-14.2

-1

-1

-16.2

11

-15.8

-1

-1

-17.8

11.25

-17.6

-1

-1

-19.6

11.5

-19.9

-1

-1

-21.9

11.75

-22.7

-1

-1

-24.7

12

-25.9

-1

-1

-27.9

12.25

-29

-1

-1

-31

12.5

-31.7

-1

-1

-33.7

12.75

-33.7

-1

-1

-35.7

13

-35

-1

-1

-37

13.25

-35.8

-1

-1

-37.8

13.5

-36.3

-1

-1

-38.3

13.75

-36.6

-1

-1

-38.6

14

-36.8

-1

-1

-38.8
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Appendix C: Reconstitution of different reagents for CE peak assignment.

1 M HEPES, pH 7
80% glycerol
1 M MgCl2
0.5 M DTT
40 mM NAD+
water
ARTD10 cat, ~5mg/mL in
50 mM pH 4.5 ammonium
acetate
Tm

(A)
unmodified
ARTD10 cat
15 µL

(B)
NAD+ +
(A)
2.5 µL
12.5 µL

(C)
(E)
(D) DTT
glycerol +
HEPES +
+ (A)
(A)
(A)
2 µL
4 µL
0.4 µL
11 µL
14.6 µL
13 µL

(F)
MgCl2 +
(A)
0.2 µL
14.8 µL

5 µL

5 µL

5 µL

5 µL

5 µL

5 µL

2.234 min

2.230
min

2.234 min

2.212
min

2.101
min

2.233
min

Appendix D: Conditions of ART assay on hARTD-10.

+NAD+

Incubated with β-NAD+,
30 °C, 3 h.

Lyophilized/TCA-precipitated sample
+

–NAD

Incubated without β-NAD+, 3 h;
Was not kept in ART-buffer.

50 mM pH 8 sodium phosphate
ART-buffer 1 mM DTT
4 mM MgCl2

15% acrylamide
Acid urea gel

Resolving
gel

0.9 N acetic acid
2.5 M urea

Stacking gel

7.5% acrylamide

126

0.375 M potassium acetate, pH 4
2.5 M urea

Appendix E Acid urea SDS-PAGE image of ART assay on hARTD-10 obtained by two
desalting methods.
Lyophilization

TCA precipitation
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Appendix F: Non-reducing and reducing GE images for ARTD-10 cat samples.
Non-reducing GE images: (A) incubation mixture of 2 mM DTT and ARTD-10 cat; (B)
untreated ARTD10 cat (for CE analysis); (C) negative control 2 (–NAD+); (D) stock
solution of untreated ARTD-10 cat from the Shilton Lab. Reducing GE images for
ARTD-10 cat samples: (E) negative control 2 (–NAD+); (F) treated ARTD-10 cat 2; (G)
stock solution of ARTD-10 cat from the Shilton Lab; (H) untreated ARTD-10 cat (for CE
analysis); (I) diluted negative control 2 (–NAD+).
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